158 results on '"Roland Meier"'
Search Results
2. Corrigendum: Enzymatic Synthesis of 2-Keto-3-Deoxy-6-Phosphogluconate by the 6-Phosphogluconate-Dehydratase From Caulobacter crescentus
- Author
-
Sabine Krevet, Lu Shen, Timon Bohnen, Bernhard Schoenenberger, Roland Meier, Markus Obkircher, Klara Bangert, Rudolf Koehling, Eric Allenspach, Roland Wohlgemuth, Bettina Siebers, and Christopher Bräsen
- Subjects
2-keto-3-deoxy-6-phosphogluconate ,6-phosphogluconate ,6-phosphogluconate dehydratase ,biocatalytic dehydration ,Caulobacter crescentus ,Entner-Doudoroff pathway ,Biotechnology ,TP248.13-248.65 - Published
- 2020
- Full Text
- View/download PDF
3. Enzymatic Synthesis of 2-Keto-3-Deoxy-6-Phosphogluconate by the 6-Phosphogluconate-Dehydratase From Caulobacter crescentus
- Author
-
Sabine Krevet, Lu Shen, Timon Bohnen, Bernhard Schoenenberger, Roland Meier, Markus Obkircher, Klara Bangert, Rudolf Koehling, Eric Allenspach, Roland Wohlgemuth, Bettina Siebers, and Christopher Bräsen
- Subjects
2-keto-3-deoxy-6-phosphogluconate ,6-phosphogluconate ,6-phosphogluconate dehydratase ,biocatalytic dehydration ,Caulobacter crescentus ,Entner-Doudoroff pathway ,Biotechnology ,TP248.13-248.65 - Abstract
The availability of metabolic intermediates is a prerequisite in many fields ranging from basic research, to biotechnological and biomedical applications as well as diagnostics. 2-keto-3-deoxy-6-phosphogluconate (KDPG) is the key intermediate of the Entner-Doudoroff (ED) pathway for sugar degradation and of sugar acid and sugar polymer breakdown in many organisms including human and plant pathogens. However, so far KDPG is hardly available due to missing efficient synthesis routes. We here report the efficient biocatalytic KDPG production through enzymatic dehydration of 6-phosphogluconate (6PG) up to gram scale using the 6PG dehydratase/Entner-Doudoroff dehydratase (EDD) from Caulobacter crescentus (CcEDD). The enzyme was recombinantly produced in Escherichia coli, purified to apparent homogeneity in a simple one-step procedure using nickel ion affinity chromatography, and characterized with respect to molecular and kinetic properties. The homodimeric CcEDD catalyzed the irreversible 6PG dehydration to KDPG with a Vmax of 61.6 U mg–1 and a KM of 0.3 mM for 6PG. Most importantly, the CcEDD showed sufficient long-term stability and activity to provide the enzyme in amounts and purity required for the efficient downstream synthesis of KDPG. CcEDD completely converted 1 g 6PG and a straight forward purification method yielded 0.81 g of stereochemically pure KDPG corresponding to a final yield of 90% as shown by HPLC-MS and NMR analyses.
- Published
- 2020
- Full Text
- View/download PDF
4. Functional Sphere Profiling Reveals the Complexity of Neuroblastoma Tumor-Initiating Cell Model
- Author
-
Aurélie Coulon, Marjorie Flahaut, Annick Mühlethaler-Mottet, Roland Meier, Julie Liberman, Katia Balmas-Bourloud, Katya Nardou, Pu Yan, Stéphane Tercier, Jean-Marc Joseph, Lukas Sommer, and Nicole Gross
- Subjects
Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Neuroblastoma (NB) is a neural crest-derived childhood tumor characterized by a remarkable phenotypic diversity, ranging from spontaneous regression to fatal metastatic disease. Although the cancer stem cell (CSC) model provides a trail to characterize the cells responsible for tumor onset, the NB tumor-initiating cell (TIC) has not been identified. In this study, the relevance of the CSC model in NB was investigated by taking advantage of typical functional stem cell characteristics. A predictive association was established between self-renewal, as assessed by serial sphere formation, and clinical aggressiveness in primary tumors. Moreover, cell subsets gradually selected during serial sphere culture harbored increased in vivo tumorigenicity, only highlighted in an orthotopic microenvironment. A microarray time course analysis of serial spheres passages from metastatic cells allowed us to specifically “profile” the NB stem cell-like phenotype and to identify CD133, ABC transporter, and WNT and NOTCH genes as spheres markers. On the basis of combined sphere markers expression, at least two distinct tumorigenic cell subpopulations were identified, also shown to preexist in primary NB. However, sphere markers-mediated cell sorting of parental tumor failed to recapitulate the TIC phenotype in the orthotopic model, highlighting the complexity of the CSC model. Our data support the NB stem-like cells as a dynamic and heterogeneous cell population strongly dependent on microenvironmental signals and add novel candidate genes as potential therapeutic targets in the control of high-risk NB.
- Published
- 2011
- Full Text
- View/download PDF
5. The chemokine receptor CXCR4 strongly promotes neuroblastoma primary tumour and metastatic growth, but not invasion.
- Author
-
Roland Meier, Annick Mühlethaler-Mottet, Marjorie Flahaut, Aurélie Coulon, Carlo Fusco, Fawzia Louache, Katya Auderset, Katia Balmas Bourloud, Estelle Daudigeos, Curzio Ruegg, Gilles Vassal, Nicole Gross, and Jean-Marc Joseph
- Subjects
Medicine ,Science - Abstract
Neuroblastoma (NB) is a heterogeneous, and particularly malignant childhood neoplasm in its higher stages, with a propensity to form metastasis in selected organs, in particular liver and bone marrow, and for which there is still no efficient treatment available beyond surgery. Recent evidence indicates that the CXCR4/CXCL12 chemokine/receptor axis may be involved in promoting NB invasion and metastasis. In this study, we explored the potential role of CXCR4 in the malignant behaviour of NB, using a combination of in vitro functional analyses and in vivo growth and metastasis assessment in an orthotopic NB mouse model. We show here that CXCR4 overexpression in non-metastatic CXCR4-negative NB cells IGR-NB8 and in moderately metastatic, CXCR4 expressing NB cells IGR-N91, strongly increased tumour growth of primary tumours and liver metastases, without altering the frequency or the pattern of metastasis. Moreover shRNA-mediated knock-down experiments confirmed our observations by showing that silencing CXCR4 in NB cells impairs in vitro and almost abrogates in vivo growth. High levels of CXCL12 were detected in the mouse adrenal gland (the primary tumour site), and in the liver suggesting a paracrine effect of host-derived CXCL12 on NB growth. In conclusion, this study reveals a yet unreported NB-specific predominant growth and survival-promoting role of CXCR4, which warrants a critical reconsideration of the role of CXCR4 in the malignant behaviour of NB and other cancers.
- Published
- 2007
- Full Text
- View/download PDF
6. Towards Generalizing Machine Learning Models to Detect Command and Control Attack Traffic.
- Author
-
Lina Gehri, Roland Meier, Daniel Hulliger, and Vincent Lenders
- Published
- 2023
- Full Text
- View/download PDF
7. LSPR23: A novel IDS dataset from the largest live-fire cybersecurity exercise.
- Author
-
Allard Dijk, Emre Halisdemir, Cosimo Melella, Alari Schu, Mauno Pihelgas, and Roland Meier
- Published
- 2024
- Full Text
- View/download PDF
8. Mass surveillance of VoIP calls in the data plane.
- Author
-
Ege Cem Kirci, Maria Apostolaki, Roland Meier, Ankit Singla, and Laurent Vanbever
- Published
- 2022
- Full Text
- View/download PDF
9. Towards an AI-powered Player in Cyber Defence Exercises.
- Author
-
Roland Meier, Arturs Lavrenovs, Kimmo Heinäaro, Luca Gambazzi, and Vincent Lenders
- Published
- 2021
- Full Text
- View/download PDF
10. ditto: WAN Traffic Obfuscation at Line Rate.
- Author
-
Roland Meier, Vincent Lenders, and Laurent Vanbever
- Published
- 2022
11. (Self) Driving Under the Influence: Intoxicating Adversarial Network Inputs.
- Author
-
Roland Meier, Thomas Holterbach, Stephan Keck, Matthias Stähli, Vincent Lenders, Ankit Singla, and Laurent Vanbever
- Published
- 2019
- Full Text
- View/download PDF
12. Detection of Malicious Remote Shell Sessions.
- Author
-
Pierre Dumont, Roland Meier, David Gugelmann, and Vincent Lenders
- Published
- 2019
- Full Text
- View/download PDF
13. Machine Learninģ-based Detection of C&C Channels with a Focus on the Locked Shields Cyber Defense Exercise.
- Author
-
Nicolas Känzig, Roland Meier, Luca Gambazzi, Vincent Lenders, and Laurent Vanbever
- Published
- 2019
- Full Text
- View/download PDF
14. NetHide: Secure and Practical Network Topology Obfuscation.
- Author
-
Roland Meier, Petar Tsankov, Vincent Lenders, Laurent Vanbever, and Martin T. Vechev
- Published
- 2018
15. FeedRank: A tamper- resistant method for the ranking of cyber threat intelligence feeds.
- Author
-
Roland Meier, Cornelia Scherrer, David Gugelmann, Vincent Lenders, and Laurent Vanbever
- Published
- 2018
- Full Text
- View/download PDF
16. Second-Generation Atroposelective Synthesis of KRAS G12C Covalent Inhibitor GDC-6036
- Author
-
Jie Xu, Ngiap-Kie Lim, Jacob C. Timmerman, Jeff Shen, Kyle Clagg, Ugo Orcel, Raphael Bigler, Etienne Trachsel, Roland Meier, Nicholas A. White, Johannes A. Burkhard, Lauren E. Sirois, Qingping Tian, Remy Angelaud, Stephan Bachmann, Haiming Zhang, and Francis Gosselin
- Subjects
Organic Chemistry ,Physical and Theoretical Chemistry ,Biochemistry - Published
- 2023
17. iTAP: In-network Traffic Analysis Prevention using Software-Defined Networks.
- Author
-
Roland Meier, David Gugelmann, and Laurent Vanbever
- Published
- 2017
- Full Text
- View/download PDF
18. pForest: In-Network Inference with Random Forests.
- Author
-
Coralie Busse-Grawitz, Roland Meier, Alexander Dietmüller, Tobias Bühler, and Laurent Vanbever
- Published
- 2019
19. Die Lehrer von Karl Marx: insbesondere: Nikolaus Mertes, latinisiert Martini Geistlicher Herr aus Gondenbrett Professor am Trierer Gymnasium 1832/33 Ordinarius/Klassenlehrer von Karl Marx
- Author
-
Hanns-Georg Salm, Roland Meier and Hanns-Georg Salm, Roland Meier
- Published
- 2017
20. Development and Optimization of the Manufacturing Process for RNA-Splicing Modifier Risdiplam RG7916
- Author
-
Christian Moessner, Fabienne Hoffmann-Emery, Jean-Michel Adam, Serena Fantasia, Dan Fishlock, Roland Meier, Georg Wuitschik, and Hasane Ratni
- Published
- 2022
21. Architekturmanagement ermöglicht IT-Multisourcing - Das Fallbeispiel Eidgenössisches Volkswirtschaftsdepartement.
- Author
-
Roland Meier and Oldrich Milde
- Published
- 2010
22. A Color Model for Digital Photo Printing on Silver Halide Paper.
- Author
-
Roland Meier and Peter Zolliker
- Published
- 2002
23. Stereoselective Synthesis of the IDO Inhibitor Navoximod
- Author
-
Frédéric St-Jean, Rémy Angelaud, Stephan Bachmann, Diane E. Carrera, Travis Remarchuk, Katarzyna A. Piechowicz, Katrin Niedermann, Hans Iding, Roland Meier, Haiyun Hou, Lauren E. Sirois, Jie Xu, Martin Olbrich, Pankaj Rege, Maud Guillemot-Plass, and Francis Gosselin
- Subjects
Indoles ,Organic Chemistry ,Imidazoles ,Stereoisomerism ,Enzyme Inhibitors - Abstract
A highly efficient asymmetric synthesis of the IDO inhibitor navoximod, featuring the stereoselective installation of two relative and two absolute stereocenters from an advanced racemic intermediate, is described. The stereocenters were set via a crystallization-induced dynamic resolution along with two selective ketone reductions: one via a biocatalytic ketoreductase transformation and one via substrate-controlled hydride delivery from LiAlH(O
- Published
- 2022
24. Personalized Portfolio Optimization Using Genetic (AI) Algorithms
- Author
-
Roland Meier and René Danzinger
- Abstract
This chapter presents a fintech-as-a-service (FaaS) solution, which enables financial advisors and wealth and asset managers to provide a “private banking-like service” to the general public. The chapter illustrates all the steps needed to structure this process as an online journey. The solution contains a full end-to-end process which advisors can use to support client advisory meetings and which can potentially also be used directly by the B2C user. To support the advisor accordingly and provide online advisory to the end customer, it is required that highly individual needs are taken into account and that truly individual and personalized portfolio proposals are generated. Traditional portfolio construction methods do not have the actual ability to take a wide range of individual preferences into account. Therefore, a new portfolio construction and optimization methodology based on “genetic algorithms” is being developed and presented in this chapter. The optimization process is built using artificial intelligence approaches. This allows optimization results to be explained based on the selected customer’s preferences. The solution is designed as an open framework, which enables additional fitness factors that represent user preferences in various dimensions to be added on a customized basis.
- Published
- 2022
25. Towards an AI-powered Player in Cyber Defence Exercises
- Author
-
Arturs Lavrenovs, Luca Gambazzi, Roland Meier, Vincent Lenders, and Kimmo Heinaaro
- Subjects
Intelligent sensor ,Fully automated ,Computer science ,business.industry ,Architecture ,Computer security ,computer.software_genre ,business ,computer ,Automation - Abstract
Cyber attacks are becoming increasingly frequent, sophisticated, and stealthy. This makes it harder for cyber defence teams to keep up, forcing them to automate their defence capabilities in order to improve their reactivity and efficiency. Therefore, we propose a fully automated cyber defence framework that no longer needs support from humans to detect and mitigate attacks within a complex infrastructure. We design our framework based on a real-world case - Locked Shields - the world's largest cyber defence exercise. In this exercise, teams have to defend their networked infrastructure against attacks, while maintaining operational services for their users. Our framework architecture connects various cyber sensors with network, device, application, and user actuators through an artificial intelligence (AI)-powered automated team in order to dynamically secure the cyber environment. To the best of our knowledge, our framework is the first attempt towards a fully automated cyber defence team that aims at protecting complex environments from sophisticated attacks.
- Published
- 2021
26. Efficient biocatalytic synthesis of D-tagatose 1,6-diphosphate by LacC-catalysed phosphorylation of D-tagatose 6-phosphate
- Author
-
Roland Wohlgemuth, Stefanie Kind, Bernhard Schoenenberger, Thorsten Eggert, Markus Obkircher, and Roland Meier
- Subjects
D-tagatose ,chemistry.chemical_compound ,chemistry ,Stereochemistry ,Metabolite ,food and beverages ,Phosphorylation ,D-tagatose-6-phosphate ,Biochemistry ,Catalysis ,Tagatose ,Biotechnology - Abstract
D-tagatose 1,6-diphosphate is an important metabolite which can be formed via the classical tagatose 6-phosphate pathway or via the tagatose 1-phosphate pathway discovered more recently. Th...
- Published
- 2019
27. A combined experimental and modelling approach for the Weimberg pathway optimisation
- Author
-
David D. van Niekerk, Junichi Enoki, Robert Kourist, Bernhard Dr. Schönenberger, Roland Meier, Jochen Niemeyer, Jacky L. Snoep, Bettina Siebers, Felix Niemeyer, Christopher Bräsen, Lu Shen, Martha Kohlhaas, Roland Wohlgemuth, Molecular Cell Physiology, and AIMMS
- Subjects
0106 biological sciences ,0301 basic medicine ,Bioconversion ,Science ,Chemie ,General Physics and Astronomy ,Lignocellulosic biomass ,Computational biology ,Oxidative phosphorylation ,01 natural sciences ,Article ,General Biochemistry, Genetics and Molecular Biology ,Metabolic engineering ,03 medical and health sciences ,Bioreactors ,Bacterial Proteins ,Xylose metabolism ,010608 biotechnology ,Caulobacter crescentus ,Computational models ,Computer Simulation ,SDG 7 - Affordable and Clean Energy ,lcsh:Science ,Hydro-Lyases ,Xylose ,Multidisciplinary ,biology ,Chemistry ,General Chemistry ,biology.organism_classification ,Enzymes ,030104 developmental biology ,Metabolic Engineering ,Models, Chemical ,Product inhibition ,Biofuels ,Biocatalysis ,Carbohydrate Metabolism ,Ketoglutaric Acids ,lcsh:Q ,NAD+ kinase ,Oxidoreductases ,Oxidation-Reduction ,Metabolic Networks and Pathways ,NADP - Abstract
The oxidative Weimberg pathway for the five-step pentose degradation to α-ketoglutarate is a key route for sustainable bioconversion of lignocellulosic biomass to added-value products and biofuels. The oxidative pathway from Caulobacter crescentus has been employed in in-vivo metabolic engineering with intact cells and in in-vitro enzyme cascades. The performance of such engineering approaches is often hampered by systems complexity, caused by non-linear kinetics and allosteric regulatory mechanisms. Here we report an iterative approach to construct and validate a quantitative model for the Weimberg pathway. Two sensitive points in pathway performance have been identified as follows: (1) product inhibition of the dehydrogenases (particularly in the absence of an efficient NAD+ recycling mechanism) and (2) balancing the activities of the dehydratases. The resulting model is utilized to design enzyme cascades for optimized conversion and to analyse pathway performance in C. cresensus cell-free extracts., Metabolic engineering is often hampered by non-linear kinetics and allosteric regulatory mechanisms. Here, the authors construct a quantitative model for the pentose degradation Weimberg pathway in Caulobacter crescentus and demonstrate its biotechnological applications in cell-free system and standard metabolic engineering.
- Published
- 2020
28. (Self) Driving Under the Influence
- Author
-
Laurent Vanbever, Matthias Stähli, Stephan Keck, Vincent Lenders, Thomas Holterbach, Roland Meier, and Ankit Singla
- Subjects
Network control ,Adversarial network ,Computer science ,05 social sciences ,050301 education ,02 engineering and technology ,Attack surface ,Service provider ,Computer security ,computer.software_genre ,Robust design ,Self driving ,0202 electrical engineering, electronic engineering, information engineering ,020201 artificial intelligence & image processing ,0503 education ,computer - Abstract
Traditional network control planes can be slow and require manual tinkering from operators to change their behavior. There is thus great interest in a faster, data-driven approach that uses signals from real-time traffic instead. However, the promise of fast and automatic reaction to data comes with new risks: malicious inputs designed towards negative outcomes for the network, service providers, users, and operators.Adversarial inputs are a well-recognized problem in other areas; we show that networking applications are susceptible to them too. We characterize the attack surface of data-driven networks and examine how attackers with different privileges---from infected hosts to operator-level access---may target network infrastructure, applications, and protocols. To illustrate the problem, we present case studies with concrete attacks on recently proposed data-driven systems.Our analysis urgently calls for a careful study of attacks and defenses in data-driven networking, with a view towards ensuring that their promise is not marred by oversights in robust design.
- Published
- 2019
29. Recovery of actinides from actinide-aluminium alloys by chlorination: Part III - Chlorination with HCl(g)
- Author
-
Rikard Malmbeck, Roland Meier, Pavel Soucek, A. Rodrigues, Thomas Fanghänel, Jean-Paul Glatz, and Olaf Walter
- Subjects
Nuclear and High Energy Physics ,Nuclear fuel ,020209 energy ,Inorganic chemistry ,chemistry.chemical_element ,02 engineering and technology ,Actinide ,021001 nanoscience & nanotechnology ,law.invention ,Metal ,Nuclear Energy and Engineering ,chemistry ,law ,Aluminium ,visual_art ,0202 electrical engineering, electronic engineering, information engineering ,visual_art.visual_art_medium ,General Materials Science ,Sublimation (phase transition) ,Molten salt ,0210 nano-technology ,Distillation ,Electrowinning - Abstract
Two steps of a pyrochemical route for the recovery of actinides from spent metallic nuclear fuel are being investigated at JRC-Karlsruhe. The first step consists in electrorefining the fuel in molten salt medium implying aluminium cathodes. The second step is a chlorination process for the separation of actinides (An) from An-Al alloys formed on the cathodes. The chlorination process, in turn, consists of three steps; the distillation of adhered salt (1), the chlorination of An-Al by HCl/Cl2 under formation of AlCl3 and An chlorides (2), and the subsequent sublimation of AlCl3 (3). In the present work UAl2, UAl3, NpAl2, and PuAl2 were chlorinated with HCl(g) in a temperature range between 300 and 400 °C forming UCl4, NpCl4 or PuCl3 as the major An containing phases, respectively. Thermodynamic calculations were carried out to support the experimental work. The results showed a high chlorination efficiency for all used starting materials and indicated that the sublimation step may not be necessary when using HCl(g).
- Published
- 2018
30. 443 Open-label, phase 2 study to assess the safety of mogamulizumab at 2 mg/kg Q4W maintenance dosing in patients with relapsed/refractory MF/SS subtypes of CTCL
- Author
-
Matthew Hruska, Karen Dwyer, Roland Meier, Floyd Fox, and Takahiro Ito
- Subjects
Pharmacology ,Cancer Research ,medicine.medical_specialty ,business.industry ,Immunology ,Phases of clinical research ,Gastroenterology ,Oncology ,Internal medicine ,Relapsed refractory ,medicine ,Mogamulizumab ,Molecular Medicine ,Immunology and Allergy ,In patient ,Dosing ,Open label ,business ,medicine.drug - Abstract
BackgroundMogamulizumab is approved in the United States, Japan, and the European Union for patients with relapsed/refractory mycosis fungoides (MF)/Sézary syndrome (SS) who have received at least one prior systemic therapy. The approved dose and schedule of mogamulizumab induction therapy are 1 mg/kg administered intravenously (IV) on Days 1, 8, 15, and 22 of the first 28-day cycle (figure 1). After induction, patients continue with 1 mg/kg IV on Days 1 and 15 of subsequent cycles. Patients must return to a clinic for administration, which can be inconvenient for patients with inadequate support systems or lack of accessibility. Additional clinic visits can also impact patient care when unforeseen circumstances, such as the COVID-19 pandemic, limit access to treatment. Limiting the number of clinic visits needed for infusion should also decrease the risk of possible exposure to nosocomial infections. This study’s purpose is to evaluate the safety, tolerability, and pharmacokinetics of mogamulizumab in patients receiving standard induction treatment followed by 2 mg/kg every 4 weeks in subsequent cycles. Data from this study will be combined with data from previous studies using modeling and simulation methods to understand how every-4-week dosing compares to every-2-week dosing in terms of exposure, safety, and activity profiles. By extending the treatment interval of mogamulizumab, patients with MF/SS will have fewer clinic visits and reduced risk of exposure to nosocomial infections.MethodsThis is a phase 2, open-label, multicenter, international study of mogamulizumab in adult patients with relapsed/refractory MF/SS who have failed at least one prior course of systemic therapy. All patients will receive mogamulizumab induction therapy. Therapy will then be administered as a 2 mg/kg IV infusion on day 1 of each subsequent 28-day cycle (figure 2). The primary objective is to evaluate the safety and tolerability of mogamulizumab 2 mg/kg administered every 4 weeks by observing the percentage of patients experiencing treatment-emergent adverse events. Secondary objectives include characterization and evaluation of mogamulizumab’s pharmacokinetic profile, immunogenicity, anti-tumor activity (global composite response and response by compartment), and pharmacodynamic profile. A maximum of 33 patients will be enrolled in this clinical trial. The study consists of a 28-day screening period followed by a treatment period of up to 2 years from Cycle 1. No dose adjustment or modification is planned or permitted. Patients will be treated until disease progression or unacceptable toxicity or upon reaching 2 years from first dose.Abstract 443 Figure 1Approved mogamulizumab dosing: 1 mg/kg every 2 weeks following inductionAbstract 443 Figure 2Study mogamulizumab dosing: 2 mg/kg every 4 weeks following inductionAcknowledgementsThe study was sponsored by Kyowa Kirin. Medical writing assistance was provided by Jonathan Mitchell, PharmD, of MedVal Scientific Information Services (Princeton, NJ, USA) and funded by Kyowa Kirin, Inc. (Princeton, NJ, USA).Trial RegistrationClinicaltrials.gov identifier: NCT04745234Ethics ApprovalThis study has been approved by the Advarra Institutional Review Board (Approval MOD00923851). Participants will be informed that their participation is voluntary and will be required to sign a statement of informed consent that meets the requirements of 21 CFR 50, local regulations, ICH guidelines, requirements of the Health Insurance Portability and Accountability Act of 1996, where applicable, and the IRB/EC or study center.
- Published
- 2021
31. Complete Accounts of Integrated Drug Discovery and Development: Recent Examples From the Pharmaceutical Industry. Volume 4
- Author
-
Jaan A. Pesti, Ahmed F. Abdel-Magid, Rajappa Vaidyanathan, Matthew Maddess, John McIntosh, Wonsuk Chang, Trung Cao, Natalia Dyatkina, Sébastien Lemaire, Marija Prhavc, Simon Wagschal, Jun Liang, Jie Xu, Scott H. Watterson, Steven R. Wisniewski, Seb Caille, Brian S. Lucas, T. G. Murali Dhar, William P. Gallagher, John R. Coombs, F. González-Bobes, Youssef El-Ahmad, Veronique Croq, Christian Wehrey, Maysoun Shomali, Laurent Schio, Christian Moessner, Fabienne Hoffmann-Emery, Jean-Michel Adam, Serena Fantasia, Daniel Fishlock, Roland Meier, Georg Wuitschik, Hasane Ratni, John Studley, Jaan A. Pesti, Ahmed F. Abdel-Magid, Rajappa Vaidyanathan, Matthew Maddess, John McIntosh, Wonsuk Chang, Trung Cao, Natalia Dyatkina, Sébastien Lemaire, Marija Prhavc, Simon Wagschal, Jun Liang, Jie Xu, Scott H. Watterson, Steven R. Wisniewski, Seb Caille, Brian S. Lucas, T. G. Murali Dhar, William P. Gallagher, John R. Coombs, F. González-Bobes, Youssef El-Ahmad, Veronique Croq, Christian Wehrey, Maysoun Shomali, Laurent Schio, Christian Moessner, Fabienne Hoffmann-Emery, Jean-Michel Adam, Serena Fantasia, Daniel Fishlock, Roland Meier, Georg Wuitschik, Hasane Ratni, and John Studley
- Published
- 2022
32. Biocatalytic asymmetric Michael addition reaction of<scp>l</scp>-arginine to fumarate for the green synthesis of N-(([(4S)-4-amino-4-carboxy-butyl]amino)iminomethyl)-<scp>l</scp>-aspartic acid lithium salt (<scp>l</scp>-argininosuccinic acid lithium salt)
- Author
-
Roland Wohlgemuth, Roland Meier, H. Brundiek, Agata Wszolek, Bernhard Schoenenberger, and Markus Obkircher
- Subjects
0301 basic medicine ,chemistry.chemical_classification ,Argininosuccinic acid ,Addition reaction ,Arginine ,Chemistry ,Stereochemistry ,General Chemical Engineering ,General Chemistry ,010402 general chemistry ,01 natural sciences ,Argininosuccinate lyase ,0104 chemical sciences ,Amino acid ,03 medical and health sciences ,chemistry.chemical_compound ,030104 developmental biology ,Biosynthesis ,Urea cycle ,Michael reaction ,Organic chemistry - Abstract
The basic natural amino acid L-argininosuccinate containing two chiral centers occurs in L-alanine, L-arginine, L-aspartate, L-glutamate and L-proline metabolic pathways and plays a role in the biosynthesis of secondary metabolites and other amino acids. It is a precursor for arginine in the urea cycle or the citrulline–NO cycle as well as a precursor to fumarate in the citric acid cycle via argininosuccinate lyase. We aimed to run part of the urea cycle in reverse by catalyzing not the elimination but the addition reaction of L-arginine to fumarate in order to synthesize L-argininosuccinate. Argininosuccinate lyase (ASL) from Saccharomyces cerevisiae has been chosen as the catalyst for this addition reaction. The selected ARG4 gene was synthesized and homogeneously expressed in E. coli leading to a highly active argininosuccinate lyase. The ASL-catalyzed addition reaction of L-arginine to fumarate has been successfully developed at gram scale. After a standard workup procedure the pure final product L-argininosuccinate has been isolated in good yield and high purity.
- Published
- 2017
33. Detection of Malicious Remote Shell Sessions
- Author
-
Roland Meier, Pierre Dumont, David Gugelmann, and Vincent Lenders
- Subjects
Password ,021110 strategic, defence & security studies ,Honeypot ,Learning classifier system ,Computer science ,business.industry ,05 social sciences ,0211 other engineering and technologies ,Botnet ,Denial-of-service attack ,02 engineering and technology ,computer.software_genre ,050601 international relations ,0506 political science ,System administrator ,Malware ,business ,computer ,Classifier (UML) ,Computer network - Abstract
Remote shell sessions via protocols such as SSH are essential for managing systems, deploying applications, and running experiments. However, combined with weak passwords or flaws in the authentication process, remote shell access becomes a major security risk, as it allows an attacker to run arbitrary commands in the name of an impersonated user or even a system administrator. For example, remote shells of weakly protected systems are often exploited in order to build large botnets, to send spam emails, or to launch distributed denial of service attacks. Also, malicious insiders in organizations often use shell sessions to access and transfer restricted data. In this work, we tackle the problem of detecting malicious shell sessions based on session logs, i.e., recorded sequences of commands that were executed over time. Our approach is to classify sessions as benign or malicious by analyzing the sequence of commands that the shell users executed. We model such sequences of commands as n-grams and use them as features to train a supervised machine learning classifier. Our evaluation, based on freely available data and data from our own honeypot infrastructure, shows that the classifier reaches a true positive rate of 99.4% and a true negative rate of 99.7% after observing only four shell commands.
- Published
- 2019
34. Machine Learninģ-based Detection of C&C Channels with a Focus on the Locked Shields Cyber Defense Exercise
- Author
-
Luca Gambazzi, Nicolas Kanzig, Vincent Lenders, Laurent Vanbever, and Roland Meier
- Subjects
021110 strategic, defence & security studies ,business.industry ,Computer science ,05 social sciences ,Digital forensics ,0211 other engineering and technologies ,Botnet ,02 engineering and technology ,Network topology ,computer.software_genre ,050601 international relations ,0506 political science ,Packet loss ,Server ,Scalability ,Malware ,business ,computer ,Heterogeneous network ,Computer network - Abstract
The diversity of applications and devices in enterprise networks combined with large traffic volumes make it inherently challenging to quickly identify malicious traffic. When incidents occur, emergency response teams often lose precious time in reverse-engineering the network topology and configuration before they can focus on malicious activities and digital forensics. In this paper, we present a system that quickly and reliably identifies Command and Control (C&C) channels without prior network knowledge. The key idea is to train a classifier using network traffic from attacks that happened in the past and use it to identify C&C connections in the current traffic of other networks. Specifically, we leverage the fact that - while benign traffic differs - malicious traffic bears similarities across networks (e.g., devices participating in a botnet act in a similar manner irrespective of their location). To ensure performance and scalability, we use a random forest classifier based on a set of computationally-efficient features tailored to the detection of C&C traffic. In order to prevent attackers from outwitting our classifier, we tune the model parameters to maximize robustness. We measure high resilience against possible attacks - e.g., attempts to camouflaging C&C flows as benign traffic - and packet loss during the inference. We have implemented our approach and we show its practicality on a real use case: Locked Shields, the world's largest cyber defense exercise. In Locked Shields, defenders have limited resources to protect a large, heterogeneous network against unknown attacks. Using recorded datasets (from 2017 and 2018) from a participating team, we show that our classifier is able to identify C&C channels with 99% precision and over 90% recall in near real time and with realistic resource requirements. If the team had used our system in 2018, it would have discovered 10 out of 12 C&C servers in the first hours of the exercise.
- Published
- 2019
35. Industry Case Studies
- Author
-
Michael Kammerer, Roland Meier, Jürgen Thun, Urs Schwitter, Pirmin Hidber, and Ralph Diodone
- Subjects
Active ingredient ,Chemistry ,Nanotechnology ,Cocrystal ,Quality by Design ,Amorphous solid ,Crystal structure prediction - Published
- 2018
36. Zirconium behaviour during electrorefining of actinide-zirconium alloy in molten LiCl-KCl on aluminium cathodes
- Author
-
Michael Krachler, Roland Meier, Rikard Malmbeck, Pavel Soucek, A. Rodrigues, Benoit Claux, Th. Fanghänel, and Jean-Paul Glatz
- Subjects
Electrorefining process ,Nuclear and High Energy Physics ,Materials science ,020209 energy ,chemistry.chemical_element ,02 engineering and technology ,LiCl–KCl molten salt ,Materials Science(all) ,Aluminium ,0202 electrical engineering, electronic engineering, information engineering ,General Materials Science ,Al cathode ,Molten salt ,Dissolution ,Eutectic system ,Zirconium ,Recovery of actinides ,Nuclear fuel ,Zirconium alloy ,Metallurgy ,Pyrochemical separation ,Treatment of spent nuclear fuel ,021001 nanoscience & nanotechnology ,chemistry ,Nuclear Energy and Engineering ,0210 nano-technology ,Electrowinning - Abstract
A pyrochemical electrorefining process for the recovery of actinides from metallic nuclear fuel based on actinide-zirconium alloys (An–Zr) in a molten salt is being investigated. In this process actinides are group-selectively recovered on solid aluminium cathodes as An–Al alloys using a LiCl–KCl eutectic melt at a temperature of 450 °C. In the present study the electrochemical behaviour of zirconium during electrorefining was investigated. The maximum amount of actinides that can be oxidised without anodic co-dissolution of zirconium was determined at a selected constant cathodic current density. The experiment consisted of three steps to assess the different stages of the electrorefining process, each of which employing a fresh aluminium cathode. The results indicate that almost a complete dissolution of the actinides without co-dissolution of zirconium is possible under the applied experimental conditions.
- Published
- 2016
- Full Text
- View/download PDF
37. On the fluorination of plutonium dioxide by ammonium hydrogen fluoride
- Author
-
E. Capelli, Benoit Claux, Roland Meier, Pavel Soucek, and Ondrej Beneš
- Subjects
Molten salt reactor ,010405 organic chemistry ,Chemistry ,Inorganic chemistry ,Organic Chemistry ,PuF3 synthesis ,010402 general chemistry ,Hydrogen fluoride ,01 natural sciences ,Biochemistry ,3. Good health ,0104 chemical sciences ,law.invention ,Inorganic Chemistry ,chemistry.chemical_compound ,Fluorination ,law ,Plutonium dioxide ,Environmental Chemistry ,Ammonium ,Literature study ,Physical and Theoretical Chemistry ,Nuclear chemistry - Abstract
A method for synthesis of PuF 3 from PuO 2 by fluorination using NH 4 HF 2 was investigated. The text comprises the literature study on the published methods for PuF 3 syntheses, principles of the applied NH 4 HF 2 fluorination, the developed experimental apparatus, the procedure of the synthesis and analysis of the product. The results showed that the proposed method is well suited for the PuF 3 preparation in a sufficient purity and with a good reaction yield.
- Published
- 2016
- Full Text
- View/download PDF
38. Highly efficient and scalable chemoenzymatic syntheses of (R)- and (S)-lactaldehydes
- Author
-
N. Schläger, T. Bisschops, H. Burger, Roland Wohlgemuth, Bernhard Dr. Schönenberger, M. A. K. Vogel, and Roland Meier
- Subjects
Fluid Flow and Transfer Processes ,010405 organic chemistry ,Chemistry ,Process Chemistry and Technology ,Enantioselective synthesis ,010402 general chemistry ,01 natural sciences ,Combinatorial chemistry ,Catalysis ,0104 chemical sciences ,Chemistry (miscellaneous) ,Yield (chemistry) ,Chemical Engineering (miscellaneous) ,Enantiomer ,Chemical purity ,Protecting group - Abstract
Biocatalytic asymmetric reductions have been key steps in the synthesis of 1,1-dimethoxy-2-propanone, catalyzed by suitable ketoreductases to (S)- and (R)-1,1-dimethoxy-2-propanol, obtained in ≥99.9% ee and excellent yield. Removal of the protecting group gave the (S)- and (R)-lactaldehydes in excellent yield and purity.
- Published
- 2016
39. Kinetics of the reaction of nitric oxide with polypyridylamine iron(II) complexes
- Author
-
Federico Roncaroli and Roland Meier
- Subjects
Otras Ciencias Químicas ,Kinetics ,Ciencias Químicas ,Ethylenediamine ,Medicinal chemistry ,NO ,Non-Heme ,Ferrous ,Nitric oxide ,chemistry.chemical_compound ,Bipyridine ,Spin-Crossover ,Reaction rate constant ,chemistry ,Spin crossover ,Materials Chemistry ,Physical and Theoretical Chemistry ,Ground state ,Nitrosyl ,CIENCIAS NATURALES Y EXACTAS - Abstract
The reactions of three polypyridylamine ferrous complexes, [Fe(TPEN)]2+, [Fe(TPPN)]2+, and [Fe(TPTN)]2+, with nitric oxide (NO) (where TPEN = N,N,N′,N′-tetrakis(2-pyridylmethyl)ethylenediamine, TPPN = N,N,N′,N′-tetrakis(2-pyridylmethyl)-1,2-propylenediamine, and TPTN = N,N,N′,N′-tetrakis(2-pyridylmethyl)trimethylenediamine) were investigated. The first two complexes, which are spin-crossover systems, presented second-order rate constants for complex formation reactions (kf) of 8.4 × 103 and 9.3 × 103 M−1 s−1, respectively (pH 5.0, 25 °C, I = 0.1 M). In contrast, the [Fe(TPTN)]2+ complex, which is in low-spin ground state, did not show any detectable reaction with NO. kf values are lower than those of high-spin Fe(II) complexes, such as [Fe(EDTA)]2− (EDTA = ethylenediaminetetraacetate) and [Fe(H2O)]2+, but higher than low-spin Fe(II) complexes, such as [Fe(CN)5(H2O)]3− and [Fe(bipyridine)3]2+. The release of NO from the [Fe(TPEN)NO]2+ and [Fe(TPPN)NO]2+ complexes were also studied, showing the values 15.6 and 17.7 s−1, respectively, comparable to the high-spin aminocarboxylate analogs. A mechanism is proposed based on the spin-crossover behavior and the geometry of these complexes and is discussed in the context of previous publications. Fil: Roncaroli, Federico. Comisión Nacional de Energía Atómica. Centro Atómico Constituyentes; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina Fil: Meier, Roland. Technische Hochschule Ingolstadt; Alemania
- Published
- 2015
40. Recombinant AroL-Catalyzed Phosphorylation for the Efficient Synthesis of Shikimic Acid 3-Phosphate
- Author
-
Agata Wszolek, Henrike Brundiek, Roland Wohlgemuth, Markus Obkircher, Bernhard Schoenenberger, and Roland Meier
- Subjects
0301 basic medicine ,Shikimic Acid ,010402 general chemistry ,01 natural sciences ,Applied Microbiology and Biotechnology ,Shikimate kinase ,Cofactor ,03 medical and health sciences ,chemistry.chemical_compound ,Enzyme Stability ,Escherichia coli ,Shikimate pathway ,Phosphorylation ,chemistry.chemical_classification ,ATP synthase ,biology ,Escherichia coli Proteins ,General Medicine ,Shikimic acid ,Recombinant Proteins ,0104 chemical sciences ,Phosphotransferases (Alcohol Group Acceptor) ,030104 developmental biology ,Enzyme ,chemistry ,Biochemistry ,biology.protein ,Molecular Medicine ,Phosphoenolpyruvate carboxykinase ,Pyruvate kinase - Abstract
Shikimic acid 3-phosphate, as a central metabolite of the shikimate pathway, is of high interest as enzyme substrate for 5-enolpyruvoyl-shikimate 3-phosphate synthase, a drug target in infectious diseases and a prime enzyme target for the herbicide glyphosate. As the important substrate shikimic acid 3-phosphate is only accessible via a chemical multi-step route, a new straightforward preparative one-step enzymatic phosphorylation of shikimate using a stable recombinant shikimate kinase has been developed for the selective phosphorylation of shikimate in the 3-position. Highly active shikimate kinase is produced by straightforward expression of a synthetic aroL gene in Escherichia coli. The time course of the shikimate kinase-catalyzed phosphorylation is investigated by 1 H- and 31 P-NMR, using the phosphoenolpyruvate/pyruvate kinase system for the regeneration of the ATP cofactor. This enables the development of a quantitative biocatalytic 3-phosphorylation of shikimic acid. After a standard workup procedure, a good yield of shikimic acid 3-phosphate, with high HPLC- and NMR purity, is obtained. This efficient biocatalytic synthesis of shikimic acid 3-phosphate is superior to any other method and has been successfully scaled up to multi-gram scale.
- Published
- 2017
41. The PAX5 oncogene is expressed in N-type neuroblastoma cells and increases tumorigenicity of a S-type cell line
- Author
-
Rolf A. Stahel, Claudio Di Paolo, Beat W. Schäfer, David R. Betts, Florian B. Baumann Kubetzko, Charlotte Maag, Roland Meier, and Andreas Himmelmann
- Subjects
Cancer Research ,Lung Neoplasms ,Cell division ,Mice, Nude ,Biology ,Mice ,Neuroblastoma ,immune system diseases ,hemic and lymphatic diseases ,Tumor Cells, Cultured ,medicine ,Animals ,Humans ,Carcinoma, Small Cell ,RNA, Small Interfering ,B-Lymphocytes ,Mice, Inbred ICR ,Oncogene ,PAX5 Transcription Factor ,Pax genes ,Neural crest ,Cancer ,General Medicine ,medicine.disease ,Phenotype ,DNA-Binding Proteins ,Cell culture ,Cancer research ,Female ,Cell Division ,Transcription Factors - Abstract
Neuroblastoma is a neural crest-derived neoplasm of infancy with poor outcome in patients with advanced disease. The oncogenic transcription factor PAX5 is an important developmental regulator and is implicated in the pathogenesis of several malignancies. Screening of neuroblastoma cell lines revealed PAX5 expression in a malignant subset of neuroblastoma cells, so-called 'N-type' cells, but not in the more benign 'S-type' neuroblastoma cells. PAX5 expression was also detected in small cell lung cancer, an aggressive tumor of neural crest origin. Based on this observation we hypothesized that there could be a relationship between PAX5 expression and the more malignant phenotype of N-type cells. Stable PAX5 expression was established in several clones of the S-type cell line CA-2E. A noticeable difference in morphology of these transfectants was observed and there was also a significant increase in the proliferation rate. Moreover, PAX5 expressing clones gained the ability to form colonies in a soft agar assay, a marker of tumorigenicity. Down-regulation of PAX5 in several N-type cell lines and one small cell lung cancer cell line utilizing small interfering RNA resulted in a significant decrease in growth rate. Taken together we propose PAX5 as an important factor for the maintenance of the proliferative and tumorigenic phenotype of neuroblastoma. Our data, together with a recent study on the role of PAX genes in cancer suggest that PAX5 and other PAX transcription factors might be valuable targets for cancer therapy.
- Published
- 2017
42. iTAP
- Author
-
Laurent Vanbever, Roland Meier, and David Gugelmann
- Subjects
Traffic analysis ,business.industry ,Computer science ,Network packet ,020206 networking & telecommunications ,02 engineering and technology ,Encryption ,Metadata ,Information sensitivity ,0202 electrical engineering, electronic engineering, information engineering ,020201 artificial intelligence & image processing ,Onion routing ,business ,Software-defined networking ,Computer network ,Anonymity - Abstract
Advances in layer 2 networking technologies have fostered the deployment of large, geographically distributed LANs. Due to their large diameter, such LANs provide many vantage points for wiretapping. As an example, Google's internal network was reportedly tapped by governmental agencies, forcing the Web giant to encrypt its internal traffic. While using encryption certainly helps, eavesdroppers can still access traffic metadata which often reveals sensitive information, such as who communicates with whom and which are the critical hubs in the infrastructure.This paper presents iTAP, a system for providing strong anonymity guarantees within a network. iTAP is network-based and can be partially deployed. Akin to onion routing, iTAP rewrites packet headers at the network edges by leveraging SDN devices. As large LANs can see millions of flows, the key challenge is to rewrite headers in a way that guarantees strong anonymity while, at the same time, scaling the control-plane (number of events) and the data-plane (number of flow rules). iTAP addresses these challenges by adopting a hybrid rewriting scheme. Specifically, iTAP scales by reusing rewriting rules across distinct flows and by distributing them on multiple switches. As reusing headers leaks information, iTAP monitors this leakage and adapts the rewriting rules before any eavesdropper could provably de-anonymize any host.We implemented iTAP and evaluated it using real network traffic traces. We show that iTAP works in practice, on existing hardware, and that deploying few SDN switches is enough to protect a large share of the network traffic.
- Published
- 2017
43. Secrets of Solid State and Aqueous Solution Structures of [Ni(tmdta)]2–
- Author
-
Jürgen Schulte, Roland Meier, Gerald Linti, Frank W. Heinemann, Carlos Platas-Iglesias, and Sunil K. Srivastava
- Subjects
Aqueous solution ,Chemistry ,Kinetics ,Molecular Conformation ,Analytical chemistry ,Solid-state ,Infrared spectroscopy ,Diamines ,Lithium ,Ligands ,Molecular conformation ,Spectral line ,Inorganic Chemistry ,symbols.namesake ,Nickel ,symbols ,Physical and Theoretical Chemistry ,Raman spectroscopy ,Chelating Agents ,Vibrational spectra - Abstract
The molecular structures of Li2[Ni(tmdta)]·5H2O (1a, tmdta = trimethylenediaminetetraacetate), {C(NH2)3}2[Ni(tmdta)]·6H2O (1b), and {Ni(H2O)6}[Ni(tmdta)]·2H2O (2a) have been determined. The central trimethylenediamine chelate ring shows half-chair (hc) geometries in 1a and 1b, while a twist-boat (tb) conformation is encountered in 2a. The coexistence of tb and hc forms in the solid state prompted us to elucidate the existence of a tb ⇌ hc equilibrium in aqueous solution. Evaluation of the data from solid state vibrational spectra (Raman and IR) for the hc and tb forms showed excellent agreement with simulated spectra obtained with DFT computations (TPSSh/TZVP). This outstanding matching between theory and experiment enabled us to build composite spectra with varying hc:tb ratios. Comparison of these results with Raman and IR spectra recorded for [Ni(tmdta)](2-) in aqueous solution revealed that simulated Raman and IR spectra with a hc:tb ratio = 2:3 match the solution spectra in an accurate way. This equilibrium ratio enabled us to compute (13)C NMR sifts for the paramagnetic solution spectrum of [Ni(tmdta)](2-) based on the relative contributions by hc and tb fractions. This leads to computed shifts that agree closely with the experimental ones. Also, the kinetics of the skeleton dynamics could be estimated quantitatively by temperature-dependent (13)C NMR spectroscopic measurements. An interesting effect encountered for the very first time here concerns a drastic intensity difference of the 10Dq band ((3)A2g → (3)T2g(F) transition) in solid state electronic spectra of tb vs hc isomers, where the intensity of this band in the case of the hc form is much lower than that of the tb conformer and thus more similar to the case of the usual Ni(II) chromophore in octahedral environment. The equilibrium constants for complex formation and protonation of Ni(II)-tmdta at low pH have been estimated by pH-dependent UV-vis titration experiments. Correlation of these data with those of Ni(II)-edta and related 3d M(II) edta and tmdta complexes allow important conclusions on the consequences resulting from extending the central diamine ring in the ligand by one methylene group in terms of both complex and protolytic stability for edta vs tmdta complexes.
- Published
- 2014
44. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two
- Author
-
Casey Ager, Matthew Reilley, Courtney Nicholas, Todd Bartkowiak, Ashvin Jaiswal, Michael Curran, Tina C. Albershardt, Anshika Bajaj, Jacob F. Archer, Rebecca S. Reeves, Lisa Y. Ngo, Peter Berglund, Jan ter Meulen, Caroline Denis, Hormas Ghadially, Thomas Arnoux, Fabien Chanuc, Nicolas Fuseri, Robert W. Wilkinson, Nicolai Wagtmann, Yannis Morel, Pascale Andre, Michael B. Atkins, Matteo S. Carlino, Antoni Ribas, John A. Thompson, Toni K. Choueiri, F. Stephen Hodi, Wen-Jen Hwu, David F. McDermott, Victoria Atkinson, Jonathan S. Cebon, Bernie Fitzharris, Michael B. Jameson, Catriona McNeil, Andrew G. Hill, Eric Mangin, Malidi Ahamadi, Marianne van Vugt, Mariëlle van Zutphen, Nageatte Ibrahim, Georgina V. Long, Robyn Gartrell, Zoe Blake, Ines Simoes, Yichun Fu, Takuro Saito, Yingzhi Qian, Yan Lu, Yvonne M. Saenger, Sadna Budhu, Olivier De Henau, Roberta Zappasodi, Kyle Schlunegger, Bruce Freimark, Jeff Hutchins, Christopher A. Barker, Jedd D. Wolchok, Taha Merghoub, Elena Burova, Omaira Allbritton, Peter Hong, Jie Dai, Jerry Pei, Matt Liu, Joel Kantrowitz, Venus Lai, William Poueymirou, Douglas MacDonald, Ella Ioffe, Markus Mohrs, William Olson, Gavin Thurston, Cristian Capasso, Federica Frascaro, Sara Carpi, Siri Tähtinen, Sara Feola, Manlio Fusciello, Karita Peltonen, Beatriz Martins, Madeleine Sjöberg, Sari Pesonen, Tuuli Ranki, Lukasz Kyruk, Erkko Ylösmäki, Vincenzo Cerullo, Fabio Cerignoli, Biao Xi, Garret Guenther, Naichen Yu, Lincoln Muir, Leyna Zhao, Yama Abassi, Víctor Cervera-Carrascón, Mikko Siurala, João Santos, Riikka Havunen, Suvi Parviainen, Akseli Hemminki, Angus Dalgleish, Satvinder Mudan, Mark DeBenedette, Ana Plachco, Alicia Gamble, Elizabeth W. Grogan, John Krisko, Irina Tcherepanova, Charles Nicolette, Pooja Dhupkar, Ling Yu, Eugenie S. Kleinerman, Nancy Gordon, Italia Grenga, Lauren Lepone, Sofia Gameiro, Karin M. Knudson, Massimo Fantini, Kwong Tsang, James Hodge, Renee Donahue, Jeffrey Schlom, Elizabeth Evans, Holm Bussler, Crystal Mallow, Christine Reilly, Sebold Torno, Maria Scrivens, Cathie Foster, Alan Howell, Leslie Balch, Alyssa Knapp, John E. Leonard, Mark Paris, Terry Fisher, Siwen Hu-Lieskovan, Ernest Smith, Maurice Zauderer, William Fogler, Marilyn Franklin, Matt Thayer, Dan Saims, John L. Magnani, Jian Gong, Michael Gray, George Fromm, Suresh de Silva, Louise Giffin, Xin Xu, Jason Rose, Taylor H. Schreiber, Sofia R. Gameiro, Paul E. Clavijo, Clint T. Allen, James W. Hodge, Kwong Y. Tsang, Jane Grogan, Nicholas Manieri, Eugene Chiang, Patrick Caplazi, Mahesh Yadav, Patrick Hagner, Hsiling Chiu, Michelle Waldman, Anke Klippel, Anjan Thakurta, Michael Pourdehnad, Anita Gandhi, Ian Henrich, Laura Quick, Rob Young, Margaret Chou, Andrew Hotson, Stephen Willingham, Po Ho, Carmen Choy, Ginna Laport, Ian McCaffery, Richard Miller, Kimberly A. Tipton, Kenneth R. Wong, Victoria Singson, Chihunt Wong, Chanty Chan, Yuanhiu Huang, Shouchun Liu, Jennifer H. Richardson, W. Michael Kavanaugh, James West, Bryan A. Irving, Ritika Jaini, Matthew Loya, Charis Eng, Melissa L. Johnson, Alex A. Adjei, Mateusz Opyrchal, Suresh Ramalingam, Pasi A. Janne, George Dominguez, Dmitry Gabrilovich, Laura de Leon, Jeannette Hasapidis, Scott J. Diede, Peter Ordentlich, Scott Cruickshank, Michael L. Meyers, Matthew D. Hellmann, Pawel Kalinski, Amer Zureikat, Robert Edwards, Ravi Muthuswamy, Nataša Obermajer, Julie Urban, Lisa H. Butterfield, William Gooding, Herbert Zeh, David Bartlett, Olga Zubkova, Larissa Agapova, Marina Kapralova, Liudmila Krasovskaia, Armen Ovsepyan, Maxim Lykov, Artem Eremeev, Vladimir Bokovanov, Olga Grigoryeva, Andrey Karpov, Sergey Ruchko, Alexandr Shuster, Danny N. Khalil, Luis Felipe Campesato, Yanyun Li, Adam S. Lazorchak, Troy D. Patterson, Yueyun Ding, Pottayil Sasikumar, Naremaddepalli Sudarshan, Nagaraj Gowda, Raghuveer Ramachandra, Dodheri Samiulla, Sanjeev Giri, Rajesh Eswarappa, Murali Ramachandra, David Tuck, Timothy Wyant, Jasmin Leshem, Xiu-fen Liu, Tapan Bera, Masaki Terabe, Birgit Bossenmaier, Gerhard Niederfellner, Yoram Reiter, Ira Pastan, Leiming Xia, Yang Xia, Yangyang Hu, Yi Wang, Yangyi Bao, Fu Dai, Shiang Huang, Elaine Hurt, Robert E. Hollingsworth, Lawrence G. Lum, Alfred E. Chang, Max S. Wicha, Qiao Li, Thomas Mace, Neil Makhijani, Erin Talbert, Gregory Young, Denis Guttridge, Darwin Conwell, Gregory B. Lesinski, Rodney JM Macedo Gonzales, Austin P. Huffman, Ximi K. Wang, Ran Reshef, Andy MacKinnon, Jason Chen, Matt Gross, Gisele Marguier, Peter Shwonek, Natalija Sotirovska, Susanne Steggerda, Francesco Parlati, Amani Makkouk, Mark K. Bennett, Ethan Emberley, Tony Huang, Weiqun Li, Silinda Neou, Alison Pan, Jing Zhang, Winter Zhang, Netonia Marshall, Thomas U. Marron, Judith Agudo, Brian Brown, Joshua Brody, Christopher McQuinn, Matthew Farren, Hannah Komar, Reena Shakya, Thomas Ludwug, Y. Maurice Morillon, Scott A. Hammond, John W. Greiner, Pulak R. Nath, Anthony L. Schwartz, Dragan Maric, David D. Roberts, Aung Naing, Kyriakos P. Papadopoulos, Karen A. Autio, Deborah J. Wong, Manish Patel, Gerald Falchook, Shubham Pant, Patrick A. Ott, Melinda Whiteside, Amita Patnaik, John Mumm, Filip Janku, Ivan Chan, Todd Bauer, Rivka Colen, Peter VanVlasselaer, Gail L. Brown, Nizar M. Tannir, Martin Oft, Jeffrey Infante, Evan Lipson, Ajay Gopal, Sattva S. Neelapu, Philippe Armand, Stephen Spurgeon, John P. Leonard, Rachel E. Sanborn, Ignacio Melero, Thomas F. Gajewski, Matthew Maurer, Serena Perna, Andres A. Gutierrez, Raphael Clynes, Priyam Mitra, Satyendra Suryawanshi, Douglas Gladstone, Margaret K. Callahan, James Crooks, Sheila Brown, Audrey Gauthier, Marc Hillairet de Boisferon, Andrew MacDonald, Laura Rosa Brunet, William T. Rothwell, Peter Bell, James M. Wilson, Fumi Sato-Kaneko, Shiyin Yao, Shannon S. Zhang, Dennis A. Carson, Cristina Guiducci, Robert L. Coffman, Kazutaka Kitaura, Takaji Matsutani, Ryuji Suzuki, Tomoko Hayashi, Ezra E. W. Cohen, David Schaer, Yanxia Li, Julie Dobkin, Michael Amatulli, Gerald Hall, Thompson Doman, Jason Manro, Frank Charles Dorsey, Lillian Sams, Rikke Holmgaard, Krishnadatt Persaud, Dale Ludwig, David Surguladze, John S. Kauh, Ruslan Novosiadly, Michael Kalos, Kyla Driscoll, Hardev Pandha, Christy Ralph, Kevin Harrington, Brendan Curti, Wallace Akerley, Sumati Gupta, Alan Melcher, David Mansfield, David R. Kaufman, Emmett Schmidt, Mark Grose, Bronwyn Davies, Roberta Karpathy, Darren Shafren, Katerina Shamalov, Cyrille Cohen, Naveen Sharma, James Allison, Tala Shekarian, Sandrine Valsesia-Wittmann, Christophe Caux, Aurelien Marabelle, Brian M. Slomovitz, Kathleen M. Moore, Hagop Youssoufian, Marshall Posner, Poonam Tewary, Alan D. Brooks, Ya-Ming Xu, Kithsiri Wijeratne, Leslie A. A. Gunatilaka, Thomas J. Sayers, John P. Vasilakos, Tesha Alston, Simon Dovedi, James Elvecrog, Iwen Grigsby, Ronald Herbst, Karen Johnson, Craig Moeckly, Stefanie Mullins, Kristen Siebenaler, Julius SternJohn, Ashenafi Tilahun, Mark A. Tomai, Katharina Vogel, Eveline E. Vietsch, Anton Wellstein, Martin Wythes, Stefano Crosignani, Joseph Tumang, Shilpa Alekar, Patrick Bingham, Sandra Cauwenberghs, Jenny Chaplin, Deepak Dalvie, Sofie Denies, Coraline De Maeseneire, JunLi Feng, Kim Frederix, Samantha Greasley, Jie Guo, James Hardwick, Stephen Kaiser, Katti Jessen, Erick Kindt, Marie-Claire Letellier, Wenlin Li, Karen Maegley, Reece Marillier, Nichol Miller, Brion Murray, Romain Pirson, Julie Preillon, Virginie Rabolli, Chad Ray, Kevin Ryan, Stephanie Scales, Jay Srirangam, Jim Solowiej, Al Stewart, Nicole Streiner, Vince Torti, Konstantinos Tsaparikos, Xianxian Zheng, Gregory Driessens, Bruno Gomes, Manfred Kraus, Chunxiao Xu, Yanping Zhang, Giorgio Kradjian, Guozhong Qin, Jin Qi, Xiaomei Xu, Bo Marelli, Huakui Yu, Wilson Guzman, Rober Tighe, Rachel Salazar, Kin-Ming Lo, Jessie English, Laszlo Radvanyi, Yan Lan, Michael Postow, Yasin Senbabaoglu, Billel Gasmi, Hong Zhong, Cailian Liu, Daniel Hirschhorhn-Cymerman, Yuanyuan Zha, Gregory Malnassy, Noreen Fulton, Jae-Hyun Park, Wendy Stock, Yusuke Nakamura, Hongtao Liu, Xiaoming Ju, Rachelle Kosoff, Kimberly Ramos, Brandon Coder, Robert Petit, Michael Princiotta, Kyle Perry, Jun Zou, Ainhoa Arina, Christian Fernandez, Wenxin Zheng, Michael A. Beckett, Helena J. Mauceri, Yang-Xin Fu, Ralph R. Weichselbaum, Whitney Lewis, Yanyan Han, Yeting Wu, Chou Yang, Jing Huang, Dongyun Wu, Jin Li, Xiaoling Liang, Xiangjun Zhou, Jinlin Hou, Raffit Hassan, Thierry Jahan, Scott J. Antonia, Hedy L. Kindler, Evan W. Alley, Somayeh Honarmand, Weiqun Liu, Meredith L. Leong, Chan C. Whiting, Nitya Nair, Amanda Enstrom, Edward E. Lemmens, Takahiro Tsujikawa, Sushil Kumar, Lisa M. Coussens, Aimee L. Murphy, Dirk G. Brockstedt, Sven D. Koch, Martin Sebastian, Christian Weiss, Martin Früh, Miklos Pless, Richard Cathomas, Wolfgang Hilbe, Georg Pall, Thomas Wehler, Jürgen Alt, Helge Bischoff, Michael Geissler, Frank Griesinger, Jens Kollmeier, Alexandros Papachristofilou, Fatma Doener, Mariola Fotin-Mleczek, Madeleine Hipp, Henoch S. Hong, Karl-Josef Kallen, Ute Klinkhardt, Claudia Stosnach, Birgit Scheel, Andreas Schroeder, Tobias Seibel, Ulrike Gnad-Vogt, Alfred Zippelius, Ha-Ram Park, Yong-Oon Ahn, Tae Min Kim, Soyeon Kim, Seulki Kim, Yu Soo Lee, Bhumsuk Keam, Dong-Wan Kim, Dae Seog Heo, Shari Pilon-Thomas, Amy Weber, Jennifer Morse, Krithika Kodumudi, Hao Liu, John Mullinax, Amod A. Sarnaik, Luke Pike, Andrew Bang, Tracy Balboni, Allison Taylor, Alexander Spektor, Tyler Wilhite, Monica Krishnan, Daniel Cagney, Brian Alexander, Ayal Aizer, Elizabeth Buchbinder, Mark Awad, Leena Ghandi, Jonathan Schoenfeld, Elizabeth Lessey-Morillon, Lisa Ridnour, Neil H. Segal, Manish Sharma, Dung T. Le, Robert L. Ferris, Andrew D. Zelenetz, Ronald Levy, Izidore S. Lossos, Caron Jacobson, Radhakrishnan Ramchandren, John Godwin, A. Dimitrios Colevas, Roland Meier, Suba Krishnan, Xuemin Gu, Jaclyn Neely, John Timmerman, Claire I. Vanpouille-Box, Silvia C. Formenti, Sandra Demaria, Erik Wennerberg, Aranzazu Mediero, Bruce N. Cronstein, Michael P. Gustafson, AriCeli DiCostanzo, Courtney Wheatley, Chul-Ho Kim, Svetlana Bornschlegl, Dennis A. Gastineau, Bruce D. Johnson, Allan B. Dietz, Cameron MacDonald, Mark Bucsek, Guanxi Qiao, Bonnie Hylander, Elizabeth Repasky, William J. Turbitt, Yitong Xu, Andrea Mastro, Connie J. Rogers, Sita Withers, Ziming Wang, Lam T. Khuat, Cordelia Dunai, Bruce R. Blazar, Dan Longo, Robert Rebhun, Steven K. Grossenbacher, Arta Monjazeb, William J. Murphy, Scott Rowlinson, Giulia Agnello, Susan Alters, David Lowe, Nicole Scharping, Ashley V. Menk, Ryan Whetstone, Xue Zeng, Greg M. Delgoffe, Patricia M. Santos, Jian Shi, Greg Delgoffe, Misako Nagasaka, Ammar Sukari, Miranda Byrne-Steele, Wenjing Pan, Xiaohong Hou, Brittany Brown, Mary Eisenhower, Jian Han, Natalie Collins, Robert Manguso, Hans Pope, Yashaswi Shrestha, Jesse Boehm, W. Nicholas Haining, Kyle R. Cron, Ayelet Sivan, Keston Aquino-Michaels, Marco Orecchioni, Davide Bedognetti, Wouter Hendrickx, Claudia Fuoco, Filomena Spada, Francesco Sgarrella, Gianni Cesareni, Francesco Marincola, Kostas Kostarelos, Alberto Bianco, Lucia Delogu, Jessica Roelands, Sabri Boughorbel, Julie Decock, Scott Presnell, Ena Wang, Franco M. Marincola, Peter Kuppen, Michele Ceccarelli, Darawan Rinchai, Damien Chaussabel, Lance Miller, Andrew Nguyen, J. Zachary Sanborn, Charles Vaske, Shahrooz Rabizadeh, Kayvan Niazi, Steven Benz, Shashank Patel, Nicholas Restifo, James White, Sam Angiuoli, Mark Sausen, Sian Jones, Maria Sevdali, John Simmons, Victor Velculescu, Luis Diaz, Theresa Zhang, Jennifer S. Sims, Sunjay M. Barton, Angela Kadenhe-Chiweshe, Filemon Dela Cruz, Andrew T. Turk, Christopher F. Mazzeo, Andrew L. Kung, Jeffrey N. Bruce, Darrell J. Yamashiro, Eileen P. Connolly, Jason Baird, Marka Crittenden, David Friedman, Hong Xiao, Rom Leidner, Bryan Bell, Kristina Young, Michael Gough, Zhen Bian, Koby Kidder, Yuan Liu, Emily Curran, Xiufen Chen, Leticia P. Corrales, Justin Kline, Ethan G. Aguilar, Jennifer Guerriero, Alaba Sotayo, Holly Ponichtera, Alexandra Pourzia, Sara Schad, Ruben Carrasco, Suzan Lazo, Roderick Bronson, Anthony Letai, Richard S. Kornbluth, Sachin Gupta, James Termini, Elizabeth Guirado, Geoffrey W. Stone, Christina Meyer, Laura Helming, Nicholas Wilson, Robert Hofmeister, Natalie J. Neubert, Laure Tillé, David Barras, Charlotte Soneson, Petra Baumgaertner, Donata Rimoldi, David Gfeller, Mauro Delorenzi, Silvia A. Fuertes Marraco, Daniel E. Speiser, Tara S. Abraham, Bo Xiang, Michael S. Magee, Scott A. Waldman, Adam E. Snook, Wojciech Blogowski, Ewa Zuba-Surma, Marta Budkowska, Daria Salata, Barbara Dolegowska, Teresa Starzynska, Leo Chan, Srinivas Somanchi, Kelsey McCulley, Dean Lee, Nico Buettner, Feng Shi, Paisley T. Myers, Stuart Curbishley, Sarah A. Penny, Lora Steadman, David Millar, Ellen Speers, Nicola Ruth, Gabriel Wong, Robert Thimme, David Adams, Mark Cobbold, Remy Thomas, Mariam Al-Muftah, Michael KK Wong, Michael Morse, Joseph I. Clark, Howard L. Kaufman, Gregory A. Daniels, Hong Hua, Tharak Rao, Janice P. Dutcher, Kai Kang, Yogen Saunthararajah, Vamsidhar Velcheti, Vikas Kumar, Firoz Anwar, Amita Verma, Zinal Chheda, Gary Kohanbash, John Sidney, Kaori Okada, Shruti Shrivastav, Diego A. Carrera, Shuming Liu, Naznin Jahan, Sabine Mueller, Ian F. Pollack, Angel M. Carcaboso, Alessandro Sette, Yafei Hou, Hideho Okada, Jessica J. Field, Weiping Zeng, Vincent FS Shih, Che-Leung Law, Peter D. Senter, Shyra J. Gardai, Nicole M. Okeley, Jennifer G. Abelin, Abu Z. Saeed, Stacy A. Malaker, Jeffrey Shabanowitz, Stephen T. Ward, Donald F. Hunt, Pam Profusek, Laura Wood, Dale Shepard, Petros Grivas, Kerstin Kapp, Barbara Volz, Detlef Oswald, Burghardt Wittig, Manuel Schmidt, Julian P. Sefrin, Lars Hillringhaus, Valeria Lifke, Alexander Lifke, Anna Skaletskaya, Jose Ponte, Thomas Chittenden, Yulius Setiady, Eva Sivado, Vincent Thomas, Meddy El Alaoui, Sébastien Papot, Charles Dumontet, Mike Dyson, John McCafferty, Said El Alaoui, Praveen K. Bommareddy, Andrew Zloza, Frederick Kohlhapp, Ann W. Silk, Sachin Jhawar, Tomas Paneque, Jenna Newman, Pedro Beltran, Felicia Cao, Bang-Xing Hong, Tania Rodriguez-Cruz, Xiao-Tong Song, Stephen Gottschalk, Hugo Calderon, Sam Illingworth, Alice Brown, Kerry Fisher, Len Seymour, Brian Champion, Emma Eriksson, Jessica Wenthe, Ann-Charlotte Hellström, Gabriella Paul-Wetterberg, Angelica Loskog, Ioanna Milenova, Magnus Ståhle, Justyna Jarblad-Leja, Gustav Ullenhag, Anna Dimberg, Rafael Moreno, Ramon Alemany, Sharad Goyal, Ann Silk, Janice Mehnert, Nashat Gabrail, Jennifer Bryan, Daniel Medina, Leah Mitchell, Kader Yagiz, Fernando Lopez, Daniel Mendoza, Anthony Munday, Harry Gruber, Douglas Jolly, Steven Fuhrmann, Sasa Radoja, Wei Tan, Aldo Pourchet, Alan Frey, Ian Mohr, Matthew Mulvey, Robert H. I. Andtbacka, Merrick Ross, Sanjiv Agarwala, Kenneth Grossmann, Matthew Taylor, John Vetto, Rogerio Neves, Adil Daud, Hung Khong, Stephanie M. Meek, Richard Ungerleider, Scott Welden, Maki Tanaka, Matthew Williams, Sigrun Hallmeyer, Bernard Fox, Zipei Feng, Christopher Paustian, Carlo Bifulco, Sadia Zafar, Otto Hemminki, Simona Bramante, Lotta Vassilev, Hongjie Wang, Andre Lieber, Silvio Hemmi, Tanja de Gruijl, Anna Kanerva, Tameem Ansari, Srividya Sundararaman, Diana Roen, Paul Lehmann, Anja C. Bloom, Lewis H. Bender, Ian B. Walters, Jay A. Berzofsky, Fanny Chapelin, Eric T. Ahrens, Jeff DeFalco, Michael Harbell, Amy Manning-Bog, Alexander Scholz, Danhui Zhang, Gilson Baia, Yann Chong Tan, Jeremy Sokolove, Dongkyoon Kim, Kevin Williamson, Xiaomu Chen, Jillian Colrain, Gregg Espiritu Santo, Ngan Nguyen, Wayne Volkmuth, Norman Greenberg, William Robinson, Daniel Emerling, Charles G. Drake, Daniel P. Petrylak, Emmanuel S. Antonarakis, Adam S. Kibel, Nancy N. Chang, Tuyen Vu, Dwayne Campogan, Heather Haynes, James B. Trager, Nadeem A. Sheikh, David I. Quinn, Peter Kirk, Murali Addepalli, Thomas Chang, Ping Zhang, Marina Konakova, Katsunobu Hagihara, Steven Pai, Laurie VanderVeen, Palakshi Obalapur, Peiwen Kuo, Phi Quach, Lawrence Fong, Deborah H. Charych, Jonathan Zalevsky, John L. Langowski, Yolanda Kirksey, Ravi Nutakki, Shalini Kolarkar, Rhoneil Pena, Ute Hoch, Stephen K. Doberstein, John Cha, Zach Mallon, Myra Perez, Amanda McDaniel, Snjezana Anand, Darrin Uecker, Richard Nuccitelli, Eva Wieckowski, Ravikumar Muthuswamy, Roshni Ravindranathan, Ariana N. Renrick, Menaka Thounaojam, Portia Thomas, Samuel Pellom, Anil Shanker, Duafalia Dudimah, Alan Brooks, Yu-Lin Su, Tomasz Adamus, Qifang Zhang, Sergey Nechaev, Marcin Kortylewski, Spencer Wei, Clark Anderson, Chad Tang, Jonathan Schoenhals, Efrosini Tsouko, John Heymach, Patricia de Groot, Joe Chang, Kenneth R. Hess, Adi Diab, Padmanee Sharma, David Hong, James Welsh, Andrea J. Parsons, Jardin Leleux, Stephane Ascarateil, Marie Eve Koziol, Dina Bai, Peihong Dai, Weiyi Wang, Ning Yang, Stewart Shuman, Liang Deng, Patrick Dillon, Gina Petroni, David Brenin, Kim Bullock, Walter Olson, Mark E. Smolkin, Kelly Smith, Carmel Nail, Craig L. Slingluff, Meenu Sharma, Faisal Fa’ak, Louise Janssen, Hiep Khong, Zhilan Xiao, Yared Hailemichael, Manisha Singh, Christina Vianden, Willem W. Overwijk, Andrea Facciabene, Pierini Stefano, Fang Chongyung, Stavros Rafail, Michael Nielsen, Peter Vanderslice, Darren G. Woodside, Robert V. Market, Ronald J. Biediger, Upendra K. Marathi, Kevin Hollevoet, Nick Geukens, Paul Declerck, Nathalie Joly, Laura McIntosh, Eustache Paramithiotis, Magnus Rizell, Malin Sternby, Bengt Andersson, Alex Karlsson-Parra, Rui Kuai, Lukasz Ochyl, Anna Schwendeman, James Moon, Weiwen Deng, Thomas E. Hudson, Bill Hanson, Chris S. Rae, Joel Burrill, Justin Skoble, George Katibah, Michele deVries, Peter Lauer, Thomas W. Dubensky, Xin Chen, Li Zhou, Xiubao Ren, Charu Aggarwal, Drishty Mangrolia, Roger Cohen, Gregory Weinstein, Matthew Morrow, Joshua Bauml, Kim Kraynyak, Jean Boyer, Jian Yan, Jessica Lee, Laurent Humeau, Sandra Oyola, Susan Duff, David Weiner, Zane Yang, Mark Bagarazzi, Douglas G. McNeel, Jens Eickhoff, Robert Jeraj, Mary Jane Staab, Jane Straus, Brian Rekoske, Glenn Liu, Marit Melssen, William Grosh, Nikole Varhegyi, Nadejda Galeassi, Donna H. Deacon, Elizabeth Gaughan, Maurizio Ghisoli, Minal Barve, Robert Mennel, Gladice Wallraven, Luisa Manning, Neil Senzer, John Nemunaitis, Masahiro Ogasawara, Shuichi Ota, Kaitlin M. Peace, Diane F. Hale, Timothy J. Vreeland, Doreen O. Jackson, John S. Berry, Alfred F. Trappey, Garth S. Herbert, Guy T. Clifton, Mark O. Hardin, Anne Toms, Na Qiao, Jennifer Litton, George E. Peoples, Elizabeth A. Mittendorf, Lila Ghamsari, Emilio Flano, Judy Jacques, Biao Liu, Jonathan Havel, Vladimir Makarov, Timothy A. Chan, Jessica B. Flechtner, John Facciponte, Stefano Ugel, Francesco De Sanctis, George Coukos, Sébastien Paris, Agnes Pottier, Laurent Levy, Bo Lu, Federica Cappuccini, Emily Pollock, Richard Bryant, Freddie Hamdy, Adrian Hill, Irina Redchenko, Hussein Sultan, Takumi Kumai, Valentyna Fesenkova, Esteban Celis, Ingrid Fernando, Claudia Palena, Justin M. David, Elizabeth Gabitzsch, Frank Jones, James L. Gulley, Mireia Uribe Herranz, Hiroshi Wada, Atsushi Shimizu, Toshihiro Osada, Satoshi Fukaya, Eiji Sasaki, Milad Abolhalaj, David Askmyr, Kristina Lundberg, Ann-Sofie Albrekt, Lennart Greiff, Malin Lindstedt, Dallas B. Flies, Tomoe Higuchi, Wojciech Ornatowski, Jaryse Harris, Sarah F. Adams, Todd Aguilera, Marjan Rafat, Laura Castellini, Hussein Shehade, Mihalis Kariolis, Dadi Jang, Rie vonEbyen, Edward Graves, Lesley Ellies, Erinn Rankin, Albert Koong, Amato Giaccia, Reham Ajina, Shangzi Wang, Jill Smith, Mariaelena Pierobon, Sandra Jablonski, Emanuel Petricoin, Louis M. Weiner, Lorcan Sherry, John Waller, Mark Anderson, Alison Bigley, Chantale Bernatchez, Cara Haymaker, Harriet Kluger, Michael Tetzlaff, Natalie Jackson, Ivan Gergel, Mary Tagliaferri, Patrick Hwu, Mario Snzol, Michael Hurwitz, Theresa Barberi, Allison Martin, Rahul Suresh, David Barakat, Sarah Harris-Bookman, Charles Drake, Alan Friedman, Sara Berkey, Stephanie Downs-Canner, Robert P. Edwards, Tyler Curiel, Kunle Odunsi, Tullia C. Bruno, Brandon Moore, Olivia Squalls, Peggy Ebner, Katherine Waugh, John Mitchell, Wilbur Franklin, Daniel Merrick, Martin McCarter, Brent Palmer, Jeffrey Kern, Dario Vignali, Jill Slansky, Anissa S. H. Chan, Xiaohong Qiu, Kathryn Fraser, Adria Jonas, Nadine Ottoson, Keith Gordon, Takashi O. Kangas, Steven Leonardo, Kathleen Ertelt, Richard Walsh, Mark Uhlik, Jeremy Graff, Nandita Bose, Ravi Gupta, Nitin Mandloi, Kiran Paul, Ashwini Patil, Rekha Sathian, Aparna Mohan, Malini Manoharan, Amitabha Chaudhuri, Yu Chen, Jing Lin, Yun-bin Ye, Chun-wei Xu, Gang Chen, Zeng-qing Guo, Andrey Komarov, Alex Chenchik, Michael Makhanov, Costa Frangou, Yi Zheng, Carla Coltharp, Darryn Unfricht, Ryan Dilworth, Leticia Fridman, Linying Liu, Milind Rajopadhye, Peter Miller, Fernando Concha-Benavente, Julie Bauman, Sumita Trivedi, Raghvendra Srivastava, James Ohr, Dwight Heron, Uma Duvvuri, Seungwon Kim, Heather Torrey, Toshi Mera, Yoshiaki Okubo, Eva Vanamee, Rosemary Foster, Denise Faustman, Edward Stack, Daisuke Izaki, Kristen Beck, Dan Tong Jia, Paul Armenta, Ashley White-Stern, Douglas Marks, Bret Taback, Basil Horst, Laura Hix Glickman, David B. Kanne, Kelsey S. Gauthier, Anthony L. Desbien, Brian Francica, Justin L. Leong, Leonard Sung, Ken Metchette, Shailaja Kasibhatla, Anne Marie Pferdekamper, Lianxing Zheng, Charles Cho, Yan Feng, Jeffery M. McKenna, John Tallarico, Steven Bender, Chudi Ndubaku, Sarah M. McWhirter, Elena Gonzalez Gugel, Charles J. M. Bell, Adiel Munk, Luciana Muniz, Nina Bhardwaj, Fei Zhao, Kathy Evans, Christine Xiao, Alisha Holtzhausen, Brent A. Hanks, Nathalie Scholler, Catherine Yin, Pien Van der Meijs, Andrew M. Prantner, Cecile M. Krejsa, Leia Smith, Brian Johnson, Daniel Branstetter, Paul L. Stein, Juan C. Jaen, Joanne BL Tan, Ada Chen, Timothy Park, Jay P. Powers, Holly Sexton, Guifen Xu, Steve W. Young, Ulrike Schindler, Wentao Deng, David John Klinke, Hannah M. Komar, Gregory Serpa, Omar Elnaggar, Philip Hart, Carl Schmidt, Mary Dillhoff, Ming Jin, Michael C. Ostrowski, Madhuri Koti, Katrina Au, Nichole Peterson, Peter Truesdell, Gillian Reid-Schachter, Charles Graham, Andrew Craig, Julie-Ann Francis, Beatrix Kotlan, Timea Balatoni, Emil Farkas, Laszlo Toth, Mihaly Ujhelyi, Akos Savolt, Zoltan Doleschall, Szabolcs Horvath, Klara Eles, Judit Olasz, Orsolya Csuka, Miklos Kasler, Gabriella Liszkay, Eytan Barnea, Collin Blakely, Patrick Flynn, Reid Goodman, Raphael Bueno, David Sugarbaker, David Jablons, V. Courtney Broaddus, Brian West, Paul R. Kunk, Joseph M. Obeid, Kevin Winters, Patcharin Pramoonjago, Edward B. Stelow, Todd W. Bauer, Osama E. Rahma, Adam Lamble, Yoko Kosaka, Fei Huang, Kate A. Saser, Homer Adams, Christina E. Tognon, Ted Laderas, Shannon McWeeney, Marc Loriaux, Jeffery W. Tyner, Brian J. Druker, Evan F. Lind, Zhuqing Liu, Shanhong Lu, Lawrence P. Kane, Gulidanna Shayan, Julia Femel, Ryan Lane, Jamie Booth, Amanda W. Lund, Anthony Rodriguez, Victor H. Engelhard, Alessandra Metelli, Bill X. Wu, Caroline W. Fugle, Rachidi Saleh, Shaoli Sun, Jennifer Wu, Bei Liu, Zihai Li, Zachary S. Morris, Emily I. Guy, Clinton Heinze, Jasdeep Kler, Monica M. Gressett, Lauryn R. Werner, Stephen D. Gillies, Alan J. Korman, Hans Loibner, Jacquelyn A. Hank, Alexander L. Rakhmilevich, Paul M. Harari, Paul M. Sondel, Erica Huelsmann, Joseph Broucek, Dorothee Brech, Tobias Straub, Martin Irmler, Johannes Beckers, Florian Buettner, Elke Schaeffeler, Matthias Schwab, Elfriede Noessner, Alison Wolfreys, Andre Da Costa, John Silva, Andrea Crosby, Ludovicus Staelens, Graham Craggs, Annick Cauvin, Sean Mason, Alison M. Paterson, Andrew C. Lake, Caroline M. Armet, Rachel W. O’Connor, Jonathan A. Hill, Emmanuel Normant, Ammar Adam, Detlev M. Biniszkiewicz, Scott C. Chappel, Vito J. Palombella, Pamela M. Holland, Annette Becker, Manmohan R. Leleti, Eric Newcomb, Joanne B. L. Tan, Suthee Rapisuwon, Arash Radfar, Kellie Gardner, Geoffrey Gibney, Michael Atkins, Keith R. Rennier, Robert Crowder, Ping Wang, Russell K. Pachynski, Rosa M. Santana Carrero, Sarai Rivas, Figen Beceren-Braun, Scott Anthony, Kimberly S. Schluns, Deepali Sawant, Maria Chikina, Hiroshi Yano, Creg Workman, Elise Salerno, Ileana Mauldin, Donna Deacon, Sofia Shea, Joel Pinczewski, Thomas Gajewski, Stefani Spranger, Brendan Horton, Akiko Suzuki, Pamela Leland, Bharat H. Joshi, Raj K. Puri, Randy F. Sweis, Riyue Bao, Jason Luke, Marie-Nicole Theodoraki, Frances-Mary Mogundo, Haejung Won, Dayson Moreira, Chan Gao, Xingli Zhao, Priyanka Duttagupta, Jeremy Jones, Massimo D’Apuzzo, and Sumanta Pal
- Subjects
0301 basic medicine ,Pharmacology ,Cancer Research ,medicine.medical_specialty ,business.industry ,medicine.medical_treatment ,Immunology ,Cancer ,Immunotherapy ,medicine.disease ,3. Good health ,03 medical and health sciences ,030104 developmental biology ,0302 clinical medicine ,Oncology ,030220 oncology & carcinogenesis ,Family medicine ,Molecular Medicine ,Immunology and Allergy ,Medicine ,business - Abstract
O1 IL-15 primes an mTOR-regulated gene-expression program to prolong anti-tumor capacity of human natural killer cells #### Andreas Lundqvist1, Vincent van Hoef1, Xiaonan Zhang1, Erik Wennerberg2, Julie Lorent1, Kristina Witt1, Laia Masvidal Sanz1, Shuo Liang1, Shannon Murray3, Ola Larsson1
- Published
- 2016
45. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one
- Author
-
Andreas Lundqvist, Vincent van Hoef, Xiaonan Zhang, Erik Wennerberg, Julie Lorent, Kristina Witt, Laia Masvidal Sanz, Shuo Liang, Shannon Murray, Ola Larsson, Rolf Kiessling, Yumeng Mao, John-William Sidhom, Catherine A. Bessell, Jonathan Havel, Jonathan Schneck, Timothy A. Chan, Eliot Sachsenmeier, David Woods, Anders Berglund, Rupal Ramakrishnan, Andressa Sodre, Jeffrey Weber, Roberta Zappasodi, Yanyun Li, Jingjing Qi, Philip Wong, Cynthia Sirard, Michael Postow, Walter Newman, Henry Koon, Vamsidhar Velcheti, Margaret K. Callahan, Jedd D. Wolchok, Taha Merghoub, Lawrence G. Lum, Minsig Choi, Archana Thakur, Abhinav Deol, Gregory Dyson, Anthony Shields, Cara Haymaker, Marc Uemura, Ravi Murthy, Marihella James, Daqing Wang, Julie Brevard, Catherine Monaghan, Suzanne Swann, James Geib, Mark Cornfeld, Srinivas Chunduru, Sudhir Agrawal, Cassian Yee, Jennifer Wargo, Sapna P. Patel, Rodabe Amaria, Hussein Tawbi, Isabella Glitza, Scott Woodman, Wen-Jen Hwu, Michael A. Davies, Patrick Hwu, Willem W. Overwijk, Chantale Bernatchez, Adi Diab, Erminia Massarelli, Neil H. Segal, Vincent Ribrag, Ignacio Melero, Tara C. Gangadhar, Walter Urba, Dirk Schadendorf, Robert L. Ferris, Roch Houot, Franck Morschhauser, Theodore Logan, Jason J. Luke, William Sharfman, Fabrice Barlesi, Patrick A. Ott, Laura Mansi, Shivaani Kummar, Gilles Salles, Cecilia Carpio, Roland Meier, Suba Krishnan, Dan McDonald, Matthew Maurer, Xuemin Gu, Jaclyn Neely, Satyendra Suryawanshi, Ronald Levy, Nikhil Khushalani, Jennifer Wu, Jinyu Zhang, Fahmin Basher, Mark Rubinstein, Mark Bucsek, Guanxi Qiao, Cameron MacDonald, Bonnie Hylander, Elizabeth Repasky, Shilpak Chatterjee, Anusara Daenthanasanmak, Paramita Chakraborty, Kyle Toth, Megan Meek, Elizabeth Garrett-Mayer, Michael Nishimura, Chrystal Paulos, Craig Beeson, Xuezhong Yu, Shikhar Mehrotra, Fei Zhao, Kathy Evans, Christine Xiao, Alisha Holtzhausen, Brent A. Hanks, Nicole Scharping, Ashley V. Menk, Rebecca Moreci, Ryan Whetstone, Rebekah Dadey, Simon Watkins, Robert Ferris, Greg M. Delgoffe, Jonathan Peled, Sean Devlin, Anna Staffas, Melissa Lumish, Kori Porosnicu Rodriguez, Katya Ahr, Miguel Perales, Sergio Giralt, Ying Taur, Eric Pamer, Marcel R. M. van den Brink, Robert Jenq, Nicola Annels, Hardev Pandha, Guy Simpson, Hugh Mostafid, Kevin Harrington, Alan Melcher, Mark Grose, Bronwyn Davies, Gough Au, Roberta Karpathy, Darren Shafren, Jacob Ricca, Dmitriy Zamarin, Luciana Batista, Florence Marliot, Angela Vasaturo, Sabrina Carpentier, Cécile Poggionovo, Véronique Frayssinet, Jacques Fieschi, Marc Van den Eynde, Franck Pagès, Jérôme Galon, Fabienne Hermitte, Sean G. Smith, Khue Nguyen, Sruthi Ravindranathan, Bhanu Koppolu, David Zaharoff, Gustavo Schvartsman, Roland Bassett, Jennifer L. McQuade, Lauren E. Haydu, Douglas Kline, Xiufen Chen, Dominick Fosco, Justin Kline, Abigail Overacre, Maria Chikina, Erin Brunazzi, Gulidanna Shayan, William Horne, Jay Kolls, Tullia C. Bruno, Creg Workman, Dario Vignali, Prasad S. Adusumilli, Ephraim A Ansa-Addo, Zihai Li, Andrew Gerry, Joseph P. Sanderson, Karen Howe, Roslin Docta, Qian Gao, Eleanor A. L. Bagg, Nicholas Tribble, Miguel Maroto, Gareth Betts, Natalie Bath, Luca Melchiori, Daniel E. Lowther, Indu Ramachandran, Gabor Kari, Samik Basu, Gwendolyn Binder-Scholl, Karen Chagin, Lini Pandite, Tom Holdich, Rafael Amado, Hua Zhang, John Glod, Donna Bernstein, Bent Jakobsen, Crystal Mackall, Ryan Wong, Jonathan D. Silk, Katherine Adams, Garth Hamilton, Alan D. Bennett, Sara Brett, Junping Jing, Adriano Quattrini, Manoj Saini, Guy Wiedermann, Joanna Brewer, MyLinh Duong, An Lu, Peter Chang, Aruna Mahendravada, Nicholas Shinners, Kevin Slawin, David M. Spencer, Aaron E. Foster, J. Henri Bayle, Cristina Bergamaschi, Sinnie Sin Man Ng, Bethany Nagy, Shawn Jensen, Xintao Hu, Candido Alicea, Bernard Fox, Barbara Felber, George Pavlakis, Jessica Chacon, Tori Yamamoto, Thomas Garrabrant, Luis Cortina, Daniel J. Powell, Marco Donia, Julie Westerlin Kjeldsen, Rikke Andersen, Marie Christine Wulff Westergaard, Valentina Bianchi, Mateusz Legut, Meriem Attaf, Garry Dolton, Barbara Szomolay, Sascha Ott, Rikke Lyngaa, Sine Reker Hadrup, Andrew Kelvin Sewell, Inge Marie Svane, Aaron Fan, Takumi Kumai, Esteban Celis, Ian Frank, Amanda Stramer, Michelle A. Blaskovich, Seth Wardell, Maria Fardis, James Bender, Michael T. Lotze, Stephanie L. Goff, Nikolaos Zacharakis, Yasmine Assadipour, Todd D. Prickett, Jared J. Gartner, Robert Somerville, Mary Black, Hui Xu, Harshini Chinnasamy, Isaac Kriley, Lily Lu, John Wunderlich, Paul F. Robbins, Steven Rosenberg, Steven A. Feldman, Kasia Trebska-McGowan, Parisa Malekzadeh, Eden Payabyab, Richard Sherry, Aishwarya Gokuldass, Charlene Kopits, Brian Rabinovich, Daniel S. Green, Olena Kamenyeva, Kathryn C. Zoon, Christina M. Annunziata, Joanne Hammill, Christopher Helsen, Craig Aarts, Jonathan Bramson, Yui Harada, Yoshikazu Yonemitsu, Kenneth Mwawasi, Galina Denisova, Rajanish Giri, Benjamin Jin, Tracy Campbell, Lindsey M. Draper, Sanja Stevanovic, Zhiya Yu, Bianca Weissbrich, Nicholas P. Restifo, Cornelia L. Trimble, Christian S. Hinrichs, Kwong Tsang, Massimo Fantini, James W. Hodge, Rika Fujii, Ingrid Fernando, Caroline Jochems, Christopher Heery, James Gulley, Patrick Soon-Shiong, Jeffrey Schlom, Weiqing Jing, Jill Gershan, Grace Blitzer, James Weber, Laura McOlash, Bryon D. Johnson, Simin Kiany, Huang Gangxiong, Eugenie S. Kleinerman, Michael Klichinsky, Marco Ruella, Olga Shestova, Saad Kenderian, Miriam Kim, John Scholler, Carl H. June, Saar Gill, Duane Moogk, Shi Zhong, Ivan Liadi, William Rittase, Victoria Fang, Janna Dougherty, Arianne Perez-Garcia, Iman Osman, Cheng Zhu, Navin Varadarajan, Alan Frey, Michelle Krogsgaard, Daniel Landi, Kristen Fousek, Malini Mukherjee, Ankita Shree, Sujith Joseph, Kevin Bielamowicz, Tiara Byrd, Nabil Ahmed, Meenakshi Hegde, Sylvia Lee, David Byrd, John Thompson, Shailender Bhatia, Scott Tykodi, Judy Delismon, Liz Chu, Siddiq Abdul-Alim, Arpy Ohanian, Anna Marie DeVito, Stanley Riddell, Kim Margolin, Isabelle Magalhaes, Jonas Mattsson, Michael Uhlin, Satoshi Nemoto, Patricio Pérez Villarroel, Ryosuke Nakagawa, James J. Mule, Adam W. Mailloux, Melinda Mata, Phuong Nguyen, Claudia Gerken, Christopher DeRenzo, Stephen Gottschalk, Mélissa Mathieu, Sandy Pelletier, John Stagg, Simon Turcotte, Nicholas Minutolo, Prannda Sharma, Andrew Tsourkas, Nadine Mockel-Tenbrinck, Daniela Mauer, Katharina Drechsel, Carola Barth, Katharina Freese, Ulrike Kolrep, Silke Schult, Mario Assenmacher, Andrew Kaiser, John Mullinax, MacLean Hall, Julie Le, Krithika Kodumudi, Erica Royster, Allison Richards, Ricardo Gonzalez, Amod Sarnaik, Shari Pilon-Thomas, Morten Nielsen, Anders Krarup-Hansen, Dorrit Hovgaard, Michael Mørk Petersen, Anand Chainsukh Loya, Niels Junker, Charlotte Rivas, Robin Parihar, Cliona M. Rooney, Haiying Qin, Sang Nguyen, Paul Su, Chad Burk, Brynn Duncan, Bong-Hyun Kim, M. Eric Kohler, Terry Fry, Arjun A. Rao, Noam Teyssier, Jacob Pfeil, Nikolaos Sgourakis, Sofie Salama, David Haussler, Sarah A. Richman, Selene Nunez-Cruz, Zack Gershenson, Zissimos Mourelatos, David Barrett, Stephan Grupp, Michael Milone, Alba Rodriguez-Garcia, Matthew K. Robinson, Gregory P. Adams, João Santos, Riikka Havunen, Mikko Siurala, Víctor Cervera-Carrascón, Suvi Parviainen, Marjukka Antilla, Akseli Hemminki, Jyothi Sethuraman, Laurelis Santiago, Jie Qing Chen, Zhimin Dai, Huizi Sha, Shu Su, Naiqing Ding, Baorui Liu, Anna Pasetto, Sarah R. Helman, Steven A. Rosenberg, Melissa Burgess, Hui Zhang, Tien Lee, Hans Klingemann, Paul Nghiem, John M. Kirkwood, John M. Rossi, Marika Sherman, Allen Xue, Yueh-wei Shen, Lynn Navale, James N. Kochenderfer, Adrian Bot, Anandaraman Veerapathran, Doris Wiener, Edmund K. Waller, Jian-Ming Li, Christopher Petersen, Bruce R. Blazar, Jingxia Li, Cynthia R. Giver, Ziming Wang, Steven K. Grossenbacher, Ian Sturgill, Robert J. Canter, William J. Murphy, Congcong Zhang, Michael C. Burger, Lukas Jennewein, Anja Waldmann, Michel Mittelbronn, Torsten Tonn, Joachim P. Steinbach, Winfried S. Wels, Jason B. Williams, Yuanyuan Zha, Thomas F. Gajewski, LaTerrica C. Williams, Giedre Krenciute, Mamta Kalra, Chrystal Louis, Gang Xin, David Schauder, Aimin Jiang, Nikhil Joshi, Weiguo Cui, Xue Zeng, Zeguo Zhao, Mohamad Hamieh, Justin Eyquem, Gertrude Gunset, Neil Bander, Michel Sadelain, David Askmyr, Milad Abolhalaj, Kristina Lundberg, Lennart Greiff, Malin Lindstedt, Helen K. Angell, Kyoung-Mee Kim, Seung-Tae Kim, Sung Kim, Alan D. Sharpe, Julia Ogden, Anna Davenport, Darren R. Hodgson, Carl Barrett, Jeeyun Lee, Elaine Kilgour, Jodi Hanson, Richard Caspell, Alexey Karulin, Paul Lehmann, Tameem Ansari, Annemarie Schiller, Srividya Sundararaman, Diana Roen, Mark Ayers, Diane Levitan, Gladys Arreaza, Fang Liu, Robin Mogg, Yung-Jue Bang, Bert O’Neil, Razvan Cristescu, Philip Friedlander, Karl Wassman, Chrisann Kyi, William Oh, Nina Bhardwaj, Svetlana Bornschlegl, Michael P. Gustafson, Dennis A. Gastineau, Ian F. Parney, Allan B. Dietz, Daniel Carvajal-Hausdorf, Nikita Mani, Kurt Schalper, David Rimm, Serena Chang, John Kurland, Christoph Matthias Ahlers, Maria Jure-Kunkel, Lewis Cohen, Holden Maecker, Holbrook Kohrt, Shuming Chen, George Crabill, Theresa Pritchard, Tracee McMiller, Drew Pardoll, Fan Pan, Suzanne Topalian, Patrick Danaher, Sarah Warren, Lucas Dennis, Andrew M. White, Leonard D’Amico, Melissa Geller, Mary L. Disis, Joseph Beechem, Kunle Odunsi, Steven Fling, Roshanak Derakhshandeh, Tonya J. Webb, Sigrid Dubois, Kevin Conlon, Bonita Bryant, Jennifer Hsu, Nancy Beltran, Jürgen Müller, Thomas Waldmann, Rebekka Duhen, Thomas Duhen, Lucas Thompson, Ryan Montler, Andrew Weinberg, Max Kates, Brandon Early, Erik Yusko, Taylor H. Schreiber, Trinity J. Bivalacqua, Jared Lunceford, Michael Nebozhyn, Erin Murphy, Andrey Loboda, David R. Kaufman, Andrew Albright, Jonathan Cheng, S. Peter Kang, Veena Shankaran, Sarina A. Piha-Paul, Jennifer Yearley, Tanguy Seiwert, Antoni Ribas, Terrill K. McClanahan, Xinwei Sher, Xiao Qiao Liu, Andrew Joe, Elizabeth Plimack, Alex Forrest-Hay, Cheryl A. Guyre, Kohei Narumiya, Marc Delcommenne, Heather A. Hirsch, Amit Deshpande, Jason Reeves, Jenny Shu, Tong Zi, Jennifer Michaelson, Debbie Law, Elizabeth Trehu, Sriram Sathyanaryanan, Brendan P. Hodkinson, Natalie A. Hutnick, Michael E. Schaffer, Michael Gormley, Tyler Hulett, Carmen Ballesteros-Merino, Christopher Dubay, Michael Afentoulis, Ashok Reddy, Larry David, Kumar Jayant, Swati Agrawal, Rajendra Agrawal, Ghayathri Jeyakumar, Seongho Kim, Heejin Kim, Cynthia Silski, Stacey Suisham, Elisabeth Heath, Ulka Vaishampayan, Natalie Vandeven, Natasja Nielsen Viller, Alison O’Connor, Hui Chen, Bolette Bossen, Eric Sievers, Robert Uger, Lisa Johnson, Hsiang-Fong Kao, Chin-Fu Hsiao, Shu-Chuan Lai, Chun-Wei Wang, Jenq-Yuh Ko, Pei-Jen Lou, Tsai-Jan Lee, Tsang-Wu Liu, Ruey-Long Hong, Staci J. Kearney, Joshua C. Black, Benjamin J. Landis, Sally Koegler, Brooke Hirsch, Roberto Gianani, Jeffrey Kim, Ming-Xiao He, Bingqing Zhang, Nan Su, Yuling Luo, Xiao-Jun Ma, Emily Park, Dae Won Kim, Domenico Copploa, Nishi Kothari, Young doo Chang, Richard Kim, Namyong Kim, Melvin Lye, Ee Wan, Hanna A. Knaus, Sofia Berglund, Hubert Hackl, Judith E. Karp, Ivana Gojo, Leo Luznik, Henoch S. Hong, Sven D. Koch, Birgit Scheel, Ulrike Gnad-Vogt, Karl-Josef Kallen, Volker Wiegand, Linus Backert, Oliver Kohlbacher, Ingmar Hoerr, Mariola Fotin-Mleczek, James M. Billingsley, Yoshinobu Koguchi, Valerie Conrad, William Miller, Iliana Gonzalez, Tomasz Poplonski, Tanisha Meeuwsen, Ana Howells-Ferreira, Rogan Rattray, Mary Campbell, Carlo Bifulco, Keith Bahjat, Brendan Curti, E-K Vetsika, G. Kallergi, Despoina Aggouraki, Z. Lyristi, P. Katsarlinos, Filippos Koinis, V. Georgoulias, Athanasios Kotsakis, Nathan T. Martin, Famke Aeffner, Logan Cerkovnik, Luke Pratte, Rebecca Kim, Joseph Krueger, Amaia Martínez-Usatorre, Camilla Jandus, Alena Donda, Laura Carretero-Iglesia, Daniel E. Speiser, Dietmar Zehn, Nathalie Rufer, Pedro Romero, Anshuman Panda, Janice Mehnert, Kim M. Hirshfield, Greg Riedlinger, Sherri Damare, Tracie Saunders, Levi Sokol, Mark Stein, Elizabeth Poplin, Lorna Rodriguez-Rodriguez, Ann Silk, Nancy Chan, Melissa Frankel, Michael Kane, Jyoti Malhotra, Joseph Aisner, Howard L. Kaufman, Siraj Ali, Jeffrey Ross, Eileen White, Gyan Bhanot, Shridar Ganesan, Anne Monette, Derek Bergeron, Amira Ben Amor, Liliane Meunier, Christine Caron, Antigoni Morou, Daniel Kaufmann, Moishe Liberman, Igor Jurisica, Anne-Marie Mes-Masson, Kamel Hamzaoui, Rejean Lapointe, Ann Mongan, Yuan-Chieh Ku, Warren Tom, Yongming Sun, Alex Pankov, Tim Looney, Janice Au-Young, Fiona Hyland, Jeff Conroy, Carl Morrison, Sean Glenn, Blake Burgher, He Ji, Mark Gardner, Angela R. Omilian, Wiam Bshara, Omilian Angela, Joseph M. Obeid, Gulsun Erdag, Mark E. Smolkin, Donna H. Deacon, James W. Patterson, Lieping Chen, Timothy N. Bullock, Craig L. Slingluff, John T. Loffredo, Raja Vuyyuru, Sophie Beyer, Vanessa M. Spires, Maxine Fox, Jon M. Ehrmann, Katrina A. Taylor, Alan J. Korman, Robert F. Graziano, David Page, Katherine Sanchez, Maritza Martel, Mariana Petaccia De Macedo, Yong Qin, Alex Reuben, Christine Spencer, Michele Guindani, Adriana Racolta, Brian Kelly, Tobin Jones, Nathan Polaske, Noah Theiss, Mark Robida, Jeffrey Meridew, Iva Habensus, Liping Zhang, Lidija Pestic-Dragovich, Lei Tang, Ryan J. Sullivan, Thomas Olencki, Thomas Hutson, Joanna Roder, Shauna Blackmon, Heinrich Roder, John Stewart, Asim Amin, Marc S. Ernstoff, Joseph I. Clark, Michael B. Atkins, Jeffrey Sosman, David F. McDermott, Harriet Kluger, Ruth Halaban, Mario Snzol, Senait Asmellash, Arni Steingrimsson, Chichung Wang, Kristin Roman, Amanda Clement, Sean Downing, Clifford Hoyt, Nathalie Harder, Guenter Schmidt, Ralf Schoenmeyer, Nicolas Brieu, Mehmet Yigitsoy, Gabriele Madonna, Gerardo Botti, Antonio Grimaldi, Paolo A. Ascierto, Ralf Huss, Maria Athelogou, Harald Hessel, Alexander Buchner, Christian Stief, Gerd Binnig, Thomas Kirchner, Shankar Sellappan, Sheeno Thyparambil, Sarit Schwartz, Fabiola Cecchi, Andrew Nguyen, Charles Vaske, Todd Hembrough, Jan Spacek, Michal Vocka, Eva Zavadova, Helena Skalova, Pavel Dundr, Lubos Petruzelka, Nicole Francis, Rau T. Tilman, Arndt Hartmann, Irena Netikova, Julia Stump, Amanda Tufman, Frank Berger, Michael Neuberger, Rudolf Hatz, Michael Lindner, Rachel E. Sanborn, John Handy, Rudolf M. Huber, Hauke Winter, Simone Reu, Cheng Sun, Weihua Xiao, Zhigang Tian, Kshitij Arora, Niyati Desai, Anupriya Kulkarni, Mihir Rajurkar, Miguel Rivera, Vikram Deshpande, David Ting, Katy Tsai, Adi Nosrati, Simone Goldinger, Omid Hamid, Alain Algazi, Paul Tumeh, Jimmy Hwang, Jacqueline Liu, Lawrence Chen, Reinhard Dummer, Michael Rosenblum, Adil Daud, Tsu-Shuen Tsao, Julia Ashworth-Sharpe, Donald Johnson, Srabani Bhaumik, Christopher Bieniarz, Joseph Couto, Michael Farrell, Mahsa Ghaffari, Antony Hubbard, Jerome Kosmeder, Cleo Lee, Erin Marner, Diana Uribe, Hongjun Zhang, Jian Zhang, Wenjun Zhang, Yifei Zhu, Larry Morrison, Takahiro Tsujikawa, Rohan N. Borkar, Vahid Azimi, Sushil Kumar, Guillaume Thibault, Motomi Mori, Edward El Rassi, Daniel R. Clayburgh, Molly F. Kulesz-Martin, Paul W. Flint, Lisa M. Coussens, Lisa Villabona, Giuseppe V. Masucci, Gary Geiss, Brian Birditt, Qian Mei, Alan Huang, Maribeth A. Eagan, Eduardo Ignacio, Nathan Elliott, Dwayne Dunaway, Jaemyeong Jung, Chris Merritt, Isaac Sprague, Philippa Webster, Yan Liang, Jessica Wenthe, Gunilla Enblad, Hannah Karlsson, Magnus Essand, Barbara Savoldo, Gianpietro Dotti, Martin Höglund, Malcolm K. Brenner, Hans Hagberg, Angelica Loskog, Matthew J. Bernett, Gregory L. Moore, Michael Hedvat, Christine Bonzon, Seung Chu, Rumana Rashid, Kendra N. Avery, Umesh Muchhal, John Desjarlais, Matthew Kraman, Katarzyna Kmiecik, Natalie Allen, Mustapha Faroudi, Carlo Zimarino, Mateusz Wydro, Jacqueline Doody, Sreesha P. Srinivasa, Nagaraja Govindappa, Praveen Reddy, Aparajita Dubey, Sankar Periyasamy, Madhukara Adekandi, Chaitali Dey, Mary Joy, Pieter Fokko van Loo, Henrike Veninga, Setareh Shamsili, Mark Throsby, Harry Dolstra, Lex Bakker, Ajjai Alva, Juergen Gschwendt, Yohann Loriot, Joaquim Bellmunt, Dai Feng, Christian Poehlein, Thomas Powles, Emmanuel S. Antonarakis, Charles G. Drake, Haiyan Wu, Johann De Bono, Rajat Bannerji, John Byrd, Gareth Gregory, Stephen Opat, Jake Shortt, Andrew J. Yee, Noopur Raje, Seth Thompson, Arun Balakumaran, Shaji Kumar, Brian I. Rini, Toni K. Choueiri, Mariangela Mariani, Laurence Albiges, John B. Haanen, James Larkin, Manuela Schmidinger, Domenico Magazzù, Alessandra di Pietro, Robert J. Motzer, Troels Holz Borch, Per Kongsted, Magnus Pedersen, Özcan Met, Karim Boudadi, Hao Wang, James Vasselli, Jan E. Baughman, Jon Wigginton, Rehab Abdallah, Ashley Ross, Jiwon Park, Steven Grossenbacher, Jesus I. Luna, Sita Withers, William Culp, Mingyi Chen, Arta Monjazeb, Michael S. Kent, Smita Chandran, David Danforth, James Yang, Christopher Klebanoff, Stephanie Goff, Biman Paria, Arvind Sabesan, Abhishek Srivastava, Udai Kammula, Jon Richards, Mark Faries, Robert H. I. Andtbacka, Luis A. Diaz, Dung T. Le, Takayuki Yoshino, Thierry André, Johanna Bendell, Minori Koshiji, Yayan Zhang, S Peter Kang, Bao Lam, Dirk Jäger, Todd M. Bauer, Judy S. Wang, Jean K. Lee, Gulam A. Manji, Ragini Kudchadkar, John S. Kauh, Shande Tang, Naomi Laing, Gerald Falchook, Edward B. Garon, Balazs Halmos, Hui Rina, Natasha Leighl, Sung Sook Lee, William Walsh, Konstanin Dragnev, Bilal Piperdi, Luis Paz-Ares Rodriguez, Nabeegha Shinwari, Ziewn Wei, Mary L Maas, Michael Deeds, Adam Armstrong, Tim Peterson, Sue Steinmetz, Thomas Herzog, Floor J. Backes, Larry Copeland, Maria Del Pilar Estevez Diz, Thomas W. Hare, Warner Huh, Byoung-Gie Kim, Kathleen M. Moore, Ana Oaknin, William Small, Krishnansu S. Tewari, Bradley J. Monk, Ashish M. Kamat, Kijoeng Nam, Maria De Santis, Robert Dreicer, Noah M. Hahn, Rodolfo Perini, Arlene Siefker-Radtke, Guru Sonpavde, Ronald de Wit, J. Alfred Witjes, Stephen Keefe, Dean Bajorin, Philippe Armand, John Kuruvilla, Craig Moskowitz, Mehdi Hamadani, Pier Luigi Zinzani, Sabine Chlosta, Nancy Bartlett, Rachel Sabado, Yvonne Saenger, Loging William, Michael Joseph Donovan, Erlinda Sacris, John Mandeli, Andres M. Salazar, John Powderly, Joshua Brody, John Nemunaitis, Leisha Emens, Amita Patnaik, Ian McCaffery, Richard Miller, Ginna Laport, Andrew L. Coveler, David C. Smith, Juneko E. Grilley-Olson, Sanjay Goel, Shyra J. Gardai, Che-Leung Law, Gary Means, Thomas Manley, Kristen A. Marrone, Gary Rosner, Valsamo Anagnostou, Joanne Riemer, Jessica Wakefield, Cynthia Zanhow, Stephen Baylin, Barbara Gitlitz, Julie Brahmer, Sabina Signoretti, Wenting Li, Charles Schloss, Jean-Marie Michot, Wei Ding, Beth Christian, Patricia Marinello, Margaret Shipp, Yana G. Najjar, null Lin, Lisa H. Butterfield, Ahmad A. Tarhini, Diwakar Davar, Hassane Zarour, Elizabeth Rush, Cindy Sander, Siqing Fu, Todd Bauer, Chris Molineaux, Mark K. Bennett, Keith W. Orford, Kyriakos P. Papadopoulos, Sukhmani K. Padda, Sumit A. Shah, A Dimitrios Colevas, Sujata Narayanan, George A. Fisher, Dana Supan, Heather A. Wakelee, Rhonda Aoki, Mark D. Pegram, Victor M. Villalobos, Jie Liu, Chris H. Takimoto, Mark Chao, Jens-Peter Volkmer, Ravindra Majeti, Irving L. Weissman, Branimir I. Sikic, Wendy Yu, Alison Conlin, Janet Ruzich, Stacy Lewis, Anupama Acheson, Kathleen Kemmer, Kelly Perlewitz, Nicole M. Moxon, Staci Mellinger, Heather McArthur, Trine Juhler-Nøttrup, Jayesh Desai, Ben Markman, Shahneen Sandhu, Hui Gan, Michael L. Friedlander, Ben Tran, Tarek Meniawy, Joanne Lundy, Duncan Colyer, Malaka Ameratunga, Christie Norris, Jason Yang, Kang Li, Lai Wang, Lusong Luo, Zhen Qin, Song Mu, Xuemei Tan, James Song, Michael Millward, Matthew H. G. Katz, Todd W. Bauer, Gauri R. Varadhachary, Nicolas Acquavella, Nipun Merchant, Gina Petroni, Osama E. Rahma, Mei Chen, Yang Song, Markus Puhlmann, Arun Khattri, Ryan Brisson, Christopher Harvey, Jatin Shah, Maria Victoria Mateos, Morio Matsumoto, Hilary Blacklock, Albert Oriol Rocafiguera, Hartmut Goldschmidt, Shinsuke Iida, Dina Ben Yehuda, Enrique Ocio, Paula Rodríguez-Otero, Sundar Jagannath, Sagar Lonial, Uma Kher, Jesus San-Miguel, Moacyr Ribeiro de Oliveira, Habte Yimer, Robert Rifkin, Fredrik Schjesvold, Razi Ghori, Anna Spreafico, Victor Lee, Roger K. C. Ngan, Ka Fai To, Myung Ju Ahn, Quan Sing Ng, Jin-Ching Lin, Ramona F. Swaby, Christine Gause, Sanatan Saraf, Anthony T. C. Chan, Elaine Lam, Nizar M. Tannir, Funda Meric-Bernstam, Matt Gross, Andy MacKinnon, Sam Whiting, Martin Voss, Evan Y. Yu, Mark R. Albertini, Erik A. Ranheim, Jacquelyn A. Hank, Cindy Zuleger, Thomas McFarland, Jennifer Collins, Erin Clements, Sharon Weber, Tracey Weigel, Heather Neuman, Greg Hartig, David Mahvi, MaryBeth Henry, Jacek Gan, Richard Yang, Lakeesha Carmichael, KyungMann Kim, Stephen D. Gillies, Paul M. Sondel, Vivek Subbiah, Lori Noffsinger, Kyle Hendricks, Marnix Bosch, Jay M. Lee, Mi-Heon Lee, Jonathan W. Goldman, Felicita E. Baratelli, Dorthe Schaue, Gerald Wang, Frances Rosen, Jane Yanagawa, Tonya C. Walser, Ying Q. Lin, Sharon Adams, Franco M. Marincola, Paul C. Tumeh, Fereidoun Abtin, Robert Suh, Karen Reckamp, William D. Wallace, Gang Zeng, David A. Elashoff, Sherven Sharma, Steven M. Dubinett, Anna C. Pavlick, Brian Gastman, Brent Hanks, Tibor Keler, Tom Davis, Laura A. Vitale, Elad Sharon, Chihiro Morishima, Martin Cheever, Christopher R. Heery, Joseph W. Kim, Elizabeth Lamping, Jennifer Marte, Sheri McMahon, Lisa Cordes, Farhad Fakhrejahani, Ravi Madan, Rachel Salazar, Maggie Zhang, Christoph Helwig, James L Gulley, Roger Li, John Amrhein, Zvi Cohen, Monique Champagne, Ashish Kamat, M. Angela Aznar, Sara Labiano, Angel Diaz-Lagares, Manel Esteller, Juan Sandoval, Susannah D. Barbee, David I. Bellovin, John C. Timmer, Nebiyu Wondyfraw, Susan Johnson, Johanna Park, Amanda Chen, Mikayel Mkrtichyan, Amir S. Razai, Kyle S. Jones, Chelsie Y. Hata, Denise Gonzalez, Quinn Deveraux, Brendan P. Eckelman, Luis Borges, Rukmini Bhardwaj, Raj K. Puri, Akiko Suzuki, Pamela Leland, Bharat H. Joshi, Todd Bartkowiak, Ashvin Jaiswal, Casey Ager, Midan Ai, Pratha Budhani, Renee Chin, David Hong, Michael Curran, William D. Hastings, Maria Pinzon-Ortiz, Masato Murakami, Jason R. Dobson, David Quinn, Joel P. Wagner, Xianhui Rong, Pamela Shaw, Ernesta Dammassa, Wei Guan, Glenn Dranoff, Alexander Cao, Ross B. Fulton, Steven Leonardo, Kathryn Fraser, Takashi O. Kangas, Nadine Ottoson, Nandita Bose, Richard D. Huhn, Jeremy Graff, Jamie Lowe, Keith Gorden, Mark Uhlik, Thomas O’Neill, Jenifer Widger, Andrea Crocker, Li-Zhen He, Jeffrey Weidlick, Karuna Sundarapandiyan, Venky Ramakrishna, James Storey, Lawrence J. Thomas, Joel Goldstein, Henry C. Marsh, Jamison Grailer, Julia Gilden, Pete Stecha, Denise Garvin, Jim Hartnett, Frank Fan, Mei Cong, Zhi-jie Jey Cheng, Marlon J. Hinner, Rachida-Siham Bel Aiba, Corinna Schlosser, Thomas Jaquin, Andrea Allersdorfer, Sven Berger, Alexander Wiedenmann, Gabriele Matschiner, Julia Schüler, Ulrich Moebius, Christine Rothe, Olwill A. Shane, Brendan Horton, Stefani Spranger, Dayson Moreira, Tomasz Adamus, Xingli Zhao, Piotr Swiderski, Sumanta Pal, Marcin Kortylewski, Alyssa Kosmides, Kevin Necochea, Kathleen M. Mahoney, Sachet A. Shukla, Nikolaos Patsoukis, Apoorvi Chaudhri, Hung Pham, Ping Hua, Xia Bu, Baogong Zhu, Nir Hacohen, Catherine J. Wu, Edward Fritsch, Vassiliki A. Boussiotis, Gordon J. Freeman, Amy E. Moran, Fanny Polesso, Lisa Lukaesko, Emelie Rådestad, Lars Egevad, Berit Sundberg, Lars Henningsohn, Victor Levitsky, William Rafelson, John L. Reagan, Loren Fast, Pottayil Sasikumar, Naremaddepalli Sudarshan, Raghuveer Ramachandra, Nagesh Gowda, Dodheri Samiulla, Talapaneni Chandrasekhar, Sreenivas Adurthi, Jiju Mani, Rashmi Nair, Amit Dhudashia, Nagaraj Gowda, Murali Ramachandra, Alexander Sankin, Benjamin Gartrell, Kerwin Cumberbatch, Hongying Huang, Joshua Stern, Mark Schoenberg, Xingxing Zang, Ryan Swanson, Michael Kornacker, Lawrence Evans, Erika Rickel, Martin Wolfson, Sandrine Valsesia-Wittmann, Tala Shekarian, François Simard, Rodrigo Nailo, Aurélie Dutour, Anne-Catherine Jallas, Christophe Caux, and Aurélien Marabelle
- Subjects
Pharmacology ,0303 health sciences ,Cancer Research ,Side effect ,business.industry ,medicine.drug_class ,Immunology ,Phases of clinical research ,Monoclonal antibody ,Phase i study ,Clinical trial ,03 medical and health sciences ,0302 clinical medicine ,Oncology ,Pharmacokinetics ,030220 oncology & carcinogenesis ,Molecular Medicine ,Immunology and Allergy ,Medicine ,In patient ,Programmed death 1 ,business ,030304 developmental biology - Published
- 2016
46. ChemInform Abstract: On the Fluorination of Plutonium Dioxide by Ammonium Hydrogen Fluoride
- Author
-
Benoit Claux, Pavel Soucek, E. Capelli, Ondrej Beneš, and Roland Meier
- Subjects
chemistry.chemical_compound ,Chemistry ,Inorganic chemistry ,Plutonium dioxide ,Ammonium ,General Medicine ,Literature study ,Hydrogen fluoride - Abstract
A method for synthesis of PuF 3 from PuO 2 by fluorination using NH 4 HF 2 was investigated. The text comprises the literature study on the published methods for PuF 3 syntheses, principles of the applied NH 4 HF 2 fluorination, the developed experimental apparatus, the procedure of the synthesis and analysis of the product. The results showed that the proposed method is well suited for the PuF 3 preparation in a sufficient purity and with a good reaction yield.
- Published
- 2016
47. FAM83A confers EGFR-TKI resistance in breast cancer cells and in mice
- Author
-
Saori Furuta, Marc E. Lenburg, Mina J. Bissell, Paraic A. Kenny, Roland Meier, Ren Xu, and Sun-Young Lee
- Subjects
MAPK/ERK pathway ,Kinase ,Reversion ,General Medicine ,Biology ,medicine.disease ,respiratory tract diseases ,Breast cancer ,Downregulation and upregulation ,In vivo ,Immunology ,Cancer cell ,medicine ,Cancer research ,PI3K/AKT/mTOR pathway ,Research Article - Abstract
Breast cancers commonly become resistant to EGFR–tyrosine kinase inhibitors (EGFR-TKIs); however, the mechanisms of this resistance remain largely unknown. We hypothesized that resistance may originate, at least in part, from molecular alterations that activate signaling downstream of EGFR. Using a screen to measure reversion of malignant cells into phenotypically nonmalignant cells in 3D gels, we identified FAM83A as a candidate cancer-associated gene capable of conferring resistance to EGFR-TKIs. FAM83A overexpression in cancer cells increased proliferation and invasion and imparted EGFR-TKI resistance both in cultured cells and in animals. Tumor cells that survived EGFR-TKI treatment in vivo had upregulated FAM83A levels. Additionally, FAM83A overexpression dramatically increased the number and size of transformed foci in cultured cells and anchorage-independent growth in soft agar. Conversely, FAM83A depletion in cancer cells caused reversion of the malignant phenotype, delayed tumor growth in mice, and rendered cells more sensitive to EGFR-TKI. Analyses of published clinical data revealed a correlation between high FAM83A expression and breast cancer patients’ poor prognosis. We found that FAM83A interacted with and caused phosphorylation of c-RAF and PI3K p85, upstream of MAPK and downstream of EGFR. These data provide an additional mechanism by which tumor cells can become EGFR-TKI resistant.
- Published
- 2012
48. How or not to calculate Ni(II) Werner-type complexes: evaluation of quantum chemical methods
- Author
-
Markus Walther, Gerald Linti, Rudi van Eldik, Roland Meier, Ralph Puchta, and Basam M. Alzubi
- Subjects
Quantum chemical ,Nickel ,Crystallography ,chemistry.chemical_compound ,chemistry ,Salicylaldehyde ,Materials Chemistry ,chemistry.chemical_element ,Amine gas treating ,Crystal structure ,Physical and Theoretical Chemistry ,Type (model theory) ,Monoclinic crystal system - Abstract
Different semi-empirical methods (PM3(tm), AM1*, and PM6) that have parameters for Ni were evaluated for structural and energy calculations in comparison with DFT calculations (B3LYP/LANL2DZp) and X-ray structures. The reported crystal structure for K4[Ni(nta)2)] · 4H2O (nta = nitrilotriacetate, monoclinic space group P21/n (No. 14), a = 10.024(2) A, b = 10.838(2) A, c = 10.631(2) A, β = 96.46(3)°, V = 1147.6(4) A3, Z = 2) and the published X-ray structures for {(2S,3S)-1,4-dimethoxy-2,3-bis[(salicylidene)amino]-butane}nickel(II) and amine(salicylaldehyde thiosemicarbazonato)nickel(II), [Ni(AST)NH3], were used for structural evaluation. The performance of the methods was also tested for typical ligand-substitution reactions at Ni(II) centers involving displacement of NH3 by L (L = PH3, AsH3, SbH3, H2O, H2S, H2Se, H2Te) in [Ni(NH3)3NH3]2+ and [Ni(AST)NH3]. Whereas PM6 performed well for the evaluation of the structural data, AM1* was found to reproduce the energies in an excellent way.
- Published
- 2010
49. Epacadostat plus nivolumab for advanced melanoma: Updated phase 2 results of the ECHO-204 study
- Author
-
Roland Meier, Gul Serbest, Karl D. Lewis, Jonathan Bleeker, Li Zhou, Adil Daud, Mansoor N. Saleh, James C. Hu, and Matthew J. Riese
- Subjects
0301 basic medicine ,Cancer Research ,Tumor microenvironment ,business.industry ,medicine.medical_treatment ,Echo (computing) ,Immunosuppression ,Evasion (ethics) ,Immune surveillance ,03 medical and health sciences ,030104 developmental biology ,0302 clinical medicine ,Oncology ,030220 oncology & carcinogenesis ,medicine ,Cancer research ,Epacadostat ,Nivolumab ,business ,Advanced melanoma - Abstract
9511Background: Indoleamine 2,3-dioxygenase 1 (IDO1) enzyme-induced immunosuppression in the tumor microenvironment supports tumor cell evasion of immune surveillance. Epacadostat (E) is a potent a...
- Published
- 2018
50. The Wnt receptor FZD1 mediates chemoresistance in neuroblastoma through activation of the Wnt/β-catenin pathway
- Author
-
Katya Nardou, Nicole Gross, Aurélie Coulon, Jacques S. Beckmann, Danielle Martinet, Niggli Fk, Marjorie Flahaut, Jean-Marc Joseph, Annick Mühlethaler-Mottet, Roland Meier, University of Zurich, and Flahaut, M
- Subjects
Male ,Cancer Research ,Fluorescent Antibody Technique ,Small hairpin RNA ,Neuroblastoma ,Transactivation ,0302 clinical medicine ,RNA interference ,1306 Cancer Research ,In Situ Hybridization, Fluorescence ,beta Catenin ,Oligonucleotide Array Sequence Analysis ,Regulation of gene expression ,0303 health sciences ,Reverse Transcriptase Polymerase Chain Reaction ,Wnt signaling pathway ,LRP5 ,3. Good health ,Gene Expression Regulation, Neoplastic ,Caspases ,030220 oncology & carcinogenesis ,Female ,RNA Interference ,Signal Transduction ,FZD1 ,ATP Binding Cassette Transporter, Subfamily B ,Cell Survival ,Blotting, Western ,Active Transport, Cell Nucleus ,610 Medicine & health ,Biology ,Cell Line ,03 medical and health sciences ,1311 Genetics ,Cell Line, Tumor ,1312 Molecular Biology ,Genetics ,Humans ,Gene silencing ,ATP Binding Cassette Transporter, Subfamily B, Member 1 ,Molecular Biology ,030304 developmental biology ,Cell Nucleus ,Gene Expression Profiling ,Frizzled Receptors ,Wnt Proteins ,10036 Medical Clinic ,Doxorubicin ,Drug Resistance, Neoplasm ,Cancer research - Abstract
The development of chemoresistance represents a major obstacle in the successful treatment of cancers such as neuroblastoma (NB), a particularly aggressive childhood solid tumour. The mechanisms underlying the chemoresistant phenotype in NB were addressed by gene expression profiling of two doxorubicin (DoxR)-resistant vs sensitive parental cell lines. Not surprisingly, the MDR1 gene was included in the identified upregulated genes, although the highest overexpressed transcript in both cell lines was the frizzled-1 Wnt receptor (FZD1) gene, an essential component of the Wnt/beta-catenin pathway. FZD1 upregulation in resistant variants was shown to mediate sustained activation of the Wnt/beta-catenin pathway as revealed by nuclear beta-catenin translocation and target genes transactivation. Interestingly, specific micro-adapted short hairpin RNA (shRNAmir)-mediated FZD1 silencing induced parallel strong decrease in the expression of MDR1, another beta-catenin target gene, revealing a complex, Wnt/beta-catenin-mediated implication of FZD1 in chemoresistance. The significant restoration of drug sensitivity in FZD1-silenced cells confirmed the FZD1-associated chemoresistance. RNA samples from 21 patient tumours (diagnosis and postchemotherapy), showed a highly significant FZD1 and/or MDR1 overexpression after treatment, underlining a role for FZD1-mediated Wnt/beta-catenin pathway in clinical chemoresistance. Our data represent the first implication of the Wnt/beta-catenin pathway in NB chemoresistance and identify potential new targets to treat aggressive and resistant NB.
- Published
- 2009
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.